Pharmacy Podcast Network

Hospital pharmacy is evolving rapidly — and pharmacists are playing a more influential role than ever in shaping safe, personalised and effective patient care. In this first episode of a special three-part series presented in partnership with Clinigen’s Love Your Pharmacist Awards, we explore how hospital pharmacy has transformed from a traditionally dispensing-focused profession into a highly clinical, technology-enabled and collaborative discipline. Host Todd Eury welcomes Dr. Varun Sethi, SVP, Asia-Pacific and Japan Region at Clinigen, and Alison Tennant, former Chief Pharmacist and recipient of the 2025 Love Your Pharmacist Lifetime Achievement Award. Together, they discuss how pharmacists are helping solve complex treatment challenges, manage medicine shortages, support multidisciplinary clinical decisions and improve access to specialised therapies. The conversation also examines the growing influence of artificial intelligence, electronic prescribing, automation, pharmacogenomics and personalised medicine — and why human judgement, empathy and patient advocacy remain irreplaceable. The episode also looks ahead to emerging innovations including advanced formulations, precision therapies and 3D-printed medicines. At the heart of the discussion is a simple message: hospital pharmacists are often working behind the scenes, but their impact can be felt throughout the entire patient journey. The Love Your Pharmacist Awards celebrate those extraordinary contributions.

The NACDS Total Store Expo was in Boston, MA from August 15-17! Pharmacy owners, pharmacy students, and pharmacists gathered for forward thinking conversations and innovation to create more profit and better outcomes in their pharmacies. The NACDS TOTAL STORE EXPO is the largest gathering of retailers and suppliers in the health and wellness industry. Discover new and innovative products, technology and services and find the partners you need to thrive in an unpredictable consumer environment.   In this "on the street" style of interviews, our host Todd Eury, CEO and Founder of the Pharmacy Podcast Network connects with:   Stephen Beckman - YARAL Pharma Marzio Pozzuoli - NuraLogix Rob Headman - First Data Bank Justin Hammerling - Infinitrak Matt Gilbert - Medsense Anthony Dragisics - ELOS Thermal Richard Voskoboynikov - Wolters Kluwer Chris Krese - NACDS

I felt like I could record a whole series of episodes, and still not run out of topics to talk about with today’s guest, and glean her wisdom. Her own story and the health challenges of her loved ones have inspired her to become the kind of practitioner she sought. She and I agree: true healing is about supporting the body's innate ability to recover. Coming from a conventional emergency-care background, she’s built a successful concierge practice showcasing that personalized nutrition, targeted supplementation, and addressing the root causes of illness helps patients achieve lasting wellness.Dr. Pamela M. Cipriano, DNP, APRN, ACNP-BC, is the founder and president of The Practice of Health and Wellness in Thomaston, Connecticut. A board-certified Acute Care Nurse Practitioner with more than 30 years of healthcare experience, she specializes in integrative and functional medicine, helping patients with complex chronic illnesses by combining evidence-informed conventional care with personalized, root-cause approaches.Dr. Cipriano is an international speaker, published researcher, and member of the ILADS (International Lyme and Associated Diseases Society) Membership Committee. She is passionate about educating both patients and healthcare professionals on the interconnected roles of immune dysfunction, chronic infections, nutrition, environmental health, and lifestyle in achieving lasting wellness and restoring hope for those living with complex chronic disease.Connect with Dr. Pamela via:Email: pcipriano@ppmlinc.comWebsite: thepracticeofhealthandwellness.comFB: https://www.facebook.com/dr.pamela.ciprianoIG: https://www.instagram.com/practicehealthwellnessYT: https://www.youtube.com/@dr.pamelacipriano1329LI: linkedin.com/in/dr-pamela-m-cipriano-dnp-aprn-673a2224

Specialty Pharmacy Access, Innovation & Independent Pharmacy Growth   This Week in Pharmacy, we explore specialty pharmacy, pharmacy innovation, emerging career opportunities, and new business models for independent community pharmacy.   Today’s episode is sponsored by Clearway Health, Value Drug Company, and FDB (First Databank, Inc.)   First, Allison Arant of Clearway Health joins us to discuss the next phase of specialty pharmacy within hospitals and health systems.   As rare disease and specialty therapies become more complex, health systems are looking for better ways to improve medication access, strengthen continuity of care, and keep patients connected to trusted clinical teams.   Todd and Allison discuss how health-system specialty pharmacy can expand community access and improve management of complex and rare disease treatments.   Learn more: https://www.clearwayhealth.com/   National Association of Specialty Pharmacy (NASP) #inSPire2026   Next, we preview inSPire 2026, taking place September 22–25, 2026, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.   The specialty pharmacy community will come together to discuss medication access, emerging therapies, technology, patient services, clinical care, and the continued evolution of specialty pharmacy.   The Next Dose Summit   Then we welcome Jordan Smith, PharmD, AAHIVP, CPGx, and Melinda Fowler, RPh, ABAAHP, FAAFM to preview The Next Dose Summit, happening October 14–15, 2026.   RxPR and the Pharmacy Podcast Network are proud press and media partners.   The event focuses on innovation, entrepreneurship, leadership, emerging career pathways, and new opportunities for pharmacists looking beyond traditional roles.   It is designed for pharmacists, students, entrepreneurs, and healthcare leaders asking one important question:   What’s next for pharmacy — and what’s next for me?   Register here: https://www.jscommunitycare.org/store/p/2026-the-next-dose-summit-registration   Expanding Independent Pharmacy   Finally, Rick Seipp, PharmD, President and CEO of Value Drug Company, returns to discuss creative strategies for expanding independent community pharmacy.   Todd and Rick explore cash-based pharmacy, transparent pricing, clinical services, new revenue streams, and other non-PBM-dependent models that can help independent pharmacies diversify and grow.   The conversation focuses on how community pharmacies can strengthen their businesses while continuing to serve as trusted healthcare destinations.   Learn more: https://www.valuedrugco.com/   Sponsored By   Clearway Health https://www.clearwayhealth.com/   Value Drug Company https://www.valuedrugco.com/   First Databank — FDB https://www.fdbhealth.com/   TWIRx — This Week in Pharmacy is hosted by Todd S. Eury and produced by the Pharmacy Podcast Network — Amplifying the Voice of Pharmacists & Our Profession.

A strong online reputation starts with meaningful patient experiences. Join us as we explore how pharmacies can build trust, engage with their communities online, and manage their digital presence. Featuring special guest and trusted partner FlavoRx, who shares industry insights on creating positive patient experiences that inspire lasting loyalty—both in the pharmacy and online.

Thank you First Data Bank (FDB) for sponsoring this episode's coverage of the NACDS Total Store Expo! The NACDS Total Store Expo was in Boston, MA from August 15-17! Pharmacy owners, pharmacy students, and pharmacists gathered for forward thinking conversations and innovation to create more profit and better outcomes in their pharmacies. The NACDS TOTAL STORE EXPO is the largest gathering of retailers and suppliers in the health and wellness industry. Discover new and innovative products, technology and services and find the partners you need to thrive in an unpredictable consumer environment. In this "on the street" style of interviews, our host Todd Eury, CEO and Founder of the Pharmacy Podcast Network connects with: Mike Plinski - FDB (First Data Bank) Amantha Bagdon - RxPost Kris Rhea - Pharmacy Marketplace EJ George - Pharmacy Student Christopher Thomsen - CAPSA Healthcare Heather Haro - DiversifyRx Daniel Heusmann - Eyecon RxSafe

This episode explores how to navigate grief and how it can impact relationships including the one with yourself. Link to Hope Edelman's book "Motherless Daughters" https://www.hopeedelman.com/books Link to Emma Hemming Willis' book "The Unexpected Journey" https://emmahemingwillis.com/the-unexpected-journey/Link to Rx Meter Product Sleep Spray: https://myplusone.com/products/restful-sleep-magnesium-spray   TzrIckmic7Yeigg0uagt

On this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Narlyn Lopes and Megan Winebrenner of CenterWell Specialty Pharmacy to talk about how modern hub models have grown well past basic access support; they're now built to deliver a coordinated, personalized experience across the whole specialty medication journey. The conversation digs into how better technology and closer collaboration are cutting down on delays and administrative burden, so patients can start therapy sooner and stay supported once they're on treatment.

TWIRx NEWS 1. Medicare Part D Paid Nearly $588 Million for Ineligible OTC Drugs   A federal audit found that Medicare Part D sponsors made approximately $587.7 million in ineligible payments from 2021 through 2023 for medications that had effectively transitioned from prescription to over-the-counter status.   The HHS Office of Inspector General cited outdated FDA information and the lack of a clear CMS rejection timeline as major contributors.   Why it matters: This exposes a serious coordination problem across FDA data, manufacturers, CMS, health plans and pharmacy claims systems.   Pharmacists may see the rejection or payment issue at the counter, but the failure often begins far upstream.   Read the Fierce Healthcare reportRead the HHS-OIG audit 2. FDA Responds to Estradiol Patch Supply Pressure   The FDA is working with six manufacturers to improve access to estradiol transdermal patches amid increased demand.   While FDA has not declared a national shortage, availability varies by product, strength and geographic area. Manufacturers are increasing production through larger batches, added shifts and expanded capacity.   Why it matters: Pharmacists are again serving as the front line of a supply-chain challenge—helping patients locate medication, coordinating with prescribers and identifying alternatives.   Read the Reuters reportRead the FDA update 3. New RSV and COVID-19 Guidance Released   The American Academy of Pediatrics and American College of Obstetricians and Gynecologists have issued updated recommendations for RSV and COVID-19 protection during the 2026–2027 respiratory season.   Why it matters: Pharmacists may face conflicting recommendations, patient confusion and questions about eligibility.   Clear counseling and coordination with pediatric and obstetric providers will be critical.   Read the Pharmacy Times report SPECIAL ANNOUNCEMENT FROM OUTCOMES   A special update from Megan Urban and Outcomes.   Outcomes is highlighting new enhancements to its Rx30 pharmacy management platform, including a refreshed user experience, automated data-entry capabilities and support from a dedicated Client Success Team.   The program will explore how these updates can streamline pharmacy workflows, save time and support greater focus on patient care.   Presented by: Dalia Rios and Kaley LesterSeptember 9, 2026 — 1:30 p.m. ET   Register here FEATURED CONVERSATION Building a Bridge to GLP-1 Access   Our featured guest is HaVy Ngo-Hamilton, PharmD, RPh, Senior Pharmacy Director at Buzz Health.   HaVy works at the intersection of pharmacy, healthcare technology, medication affordability and prescription access.   Buzz Health operates platforms including BuzzRx, RxCompare and RxAffect, with a focus on helping connect patients, pharmacies, prescribers and prescription pricing information.   That makes today’s discussion particularly timely. THE MEDICARE GLP-1 BRIDGE   CMS launched the Medicare GLP-1 Bridge on July 1, 2026, to provide eligible Medicare Part D beneficiaries access to selected GLP-1 medications for weight management.   The demonstration runs through December 31, 2027.   Eligible beneficiaries pay $50 for a monthly supply, while the program operates outside the traditional Part D payment flow through centralized prior authorization, claims adjudication and pharmacy payment.   Eligible therapies currently include:   Foundayo®Wegovy®Zepbound®   The bigger issue is not simply GLP-1 coverage.   It is how healthcare connects eligibility, affordability, prior authorization, pharmacy workflow and patient access.   The central question for today’s discussion:   Can we create a medication-access system where patients know whether they can obtain and afford their therapy before they reach the pharmacy counter? CLOSING THOUGHT   The Medicare GLP-1 Bridge is more than another federal drug program.   It is a real-world test of how healthcare can better connect coverage, affordability, prior authorization and pharm

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Mike Muniz - NewRx Pharmacy Tim Weber - Good Neighbor Pharmacy Brian Pinto - Tiffany Natural Pharmacy Paul Shelton - LTC@Home Pharmacy Network Armawn Asgari - CurifyLabs

Psychedelics, hallucinogens, natural medicines, you name it, if it has been, is, or will be in a clinical trial, we’re covering it on this episode of the Pain Pod folks! We’ll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin’ just learnin’!You’re not going to want to miss this one!Come one, come all, to the Pain Pod!!!   TzrIckmic7Yeigg0uagt

Featured Guest: Bhuren Patel, CEO, PelMedsPresented by: SuiteRx Pharmacy Technology Platforms   Episode Focus This episode will explore how PelMeds has developed a closed-door, full-service pharmacy model centered on medication management, specialized packaging, compounding, specialty products, and coordinated delivery. PelMeds serves residential schools, group homes, hospice and palliative care organizations, assisted living residents, individual patients, and veterinary clients.   Discussion Topics   1. The PelMeds Growth StoryBhuren’s pharmacy leadership journey and how PelMeds evolved to meet increasingly complex medication needs.   2. Serving Diverse Care EnvironmentsThe operational differences involved in supporting group homes, assisted living communities, residential programs, hospice care, individual patients, and veterinary practices.   3. Medication Management and Specialized PackagingHow adherence packaging, refill coordination, delivery, and proactive communication improve safety, efficiency, and continuity of care.   4. Technology Behind the WorkflowHow pharmacy technology can connect dispensing, packaging, documentation, communication, delivery, and customer service.   5. Balancing Personal Service with ScaleMaintaining a high-touch pharmacy experience while expanding operations, services, and customer relationships.   Key Takeaway Successful pharmacy growth increasingly depends on combining technology, medication-management expertise, dependable delivery, and personalized service—not simply filling prescriptions.

As MTM evolves and pharmacies prepare for increased demand, what does success look like from both the technology side and the pharmacy operations side? Ross brings the perspective of innovation, workflow transformation, and MTM Intelligence. Jon brings the perspective of an independent pharmacy owner and operator who understands the realities of staffing shortages, prescription volume, patient expectations, and limited resources. The result is a conversation that feels less like a product discussion and more like an industry discussion about helping independent pharmacies thrive.   Guests: Jon Grice and Ross Frei

Schedule an Rx AssessmentWelcome everyone to the Bottom Line Rewind, your monthly recap of the Bottom Line Pharmacy Podcast.This month, we feature interviews on topics about Inventory, AI and Automation, the Peptide PCAC meeting, R&D Tax Credits, and Basis when buying a pharmacy.Click below to check out the full episodes:Episode 1: Inventory Management in 2026 with Jared Barton, CEO of Inventory IQEpisode 2: Inside a Pharmacy AI Bot with Ross Miller, VP of Sales at TJM LabsEpisode 3: R&D Tax Credit, Trump Accounts, Taylor Swift's WeddingEpisode 4: Peptides, Policy, and PBMs with Dr. Anne West, Clinical Pharmacist at Atrium24, Dae Y. Lee, PBM & Pharmacy Practice Group Co-Chair at Buchanan Ingersoll & Rooney, P.C.Episode 5: Understanding Basis When Buying a Pharmacy with Ollin Sykes, CPA, CMA, CITPStay connected with us:Facebook | Twitter | LinkedInYouTube | TikTok | Instagram | Blog

Today’s episode of This Week in Pharmacy — #TWIRx is sponsored by Value Drug Company and explores two major forces reshaping pharmacy: the evolution of the community pharmacy business model and the expanding role of artificial intelligence in medication optimization and value-based care. PART ONE: The Impact of the Cash-based Community Pharmacy Special Guest: Rick Seipp, PharmD President, Value Drug CompanyCommunity pharmacy is entering a new era. In Part One, Todd Eury sits down with Rick Seipp, PharmD, President of Value Drug Company, to discuss the continued evolution and expansion of independent community pharmacy and the many different business models emerging across the profession. Independent pharmacy owners are increasingly evaluating new ways to build sustainable businesses while creating greater professional freedom for pharmacists. One of the most interesting developments is the growth of cash-based and cost-plus pharmacy models that reduce or eliminate dependence on traditional insurance reimbursement and PBM-controlled prescription economics. These models can give pharmacy owners greater control over pricing, patient relationships, clinical services and the overall direction of their businesses — while allowing pharmacists to practice with significantly less interference from insurance companies and pharmacy benefit managers. Two pharmacies in the Pittsburgh region are demonstrating how powerful this model can become:Blueberry Pharmacy — Kyle McCormick, PharmD has built Blueberry Pharmacy around a transparent, cash-based model designed to simplify prescription pricing and create a more direct relationship between the pharmacist and patient.Forward Rx Pharmacy — Brandon Antinopoulos, PharmD is another emerging example of how pharmacists can create innovative pharmacy businesses built around transparency, accessibility and freedom from many of the traditional constraints of third-party reimbursement. Todd and Rick discuss what these models mean for the broader independent pharmacy marketplace and why community pharmacy may be moving toward a much more diversified future. Sponsored by Value Drug Company, a pharmacist-led wholesale distribution partner committed to supporting the continued growth and independence of community pharmacy.https://lnkd.in/ehf76qUsPART TWO: AI-Powered Medication Optimization Special Guests:Yoona Kim, PharmD, PhDCo-Founder & CEO, ArineJenny Behan, PharmDLead Clinical Pharmacist, ArineIn Part Two, #TWIRx shifts from pharmacy business innovation to one of the most important developments occurring in clinical pharmacy: the use of artificial intelligence to optimize medication therapy at scale.Arine is an AI-powered medication optimization platform designed to improve patient outcomes and reduce healthcare costs by helping ensure patients receive the most effective and appropriate medications. Listen to This Week in Pharmacy — TWIRx on the Pharmacy Podcast Network across Apple Podcasts, Spotify, Amazon Music, iHeartRadio, YouTube and all major podcast platforms. Pharmacy Podcast Network — Amplifying the Voice of Pharmacy.

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Kushal Vaghani - Denbigh Pharmacy Kevin Boesen - Outcomes Gold Eneyo - Cencora Nic Bernabe - Outcomes Steven Dolan - Monroe Pharmacy Dalia Rios - Outcomes Christian Hampel - Family Prescription Counter

Can the Body Heal Itself? A Pharmacist and Naturopath Talk Pregnancy and NutritionDr. Randi Shannon said she was going to blow our minds, and she delivered!In this episode of MaternalRx, pharmacist Danielle Plummer, PharmD, sits down with Dr. Shannon, a traditional naturopath who uses Face, Tongue and Nail Analysis, an approach she describes as rooted in thousands of years of traditional medicine.Their conversation explores pregnancy preparation, nutrition, nausea and vomiting, minerals, essential oils, disease prevention, and Dr. Shannon’s belief that the face, tongue, and fingernails can reveal clues about what is happening inside the body.The interview is followed by a commentary where Danielle puts her pharmacist hat on for an evidence-based debrief, examining several of the episode’s most surprising claims and asking an essential healthcare question: What happens when an idea sounds biologically plausible, yet the clinical evidence has not been tested?Topics include Type 1 diabetes, Down syndrome, salt intake, peppermint oil in pregnancy, cholesterol, dietary oils, pharmaceuticals, nutrient requirements, and the important distinction between traditional naturopaths and licensed naturopathic doctors. This isn’t a conversation about dismissing complementary medicine. It’s about listening with curiosity while still asking important questions: What do we know? What don’t we know? Where might an approach put a patient or pregnancy at risk, and where might it support the body’s ability to heal? Stay through the end to hear Danielle's Takeaway!Section 1: Welcome and disclaimer Meet Dr. Randi Shannon What is a naturopath? Preparing the body for pregnancy Nausea in pregnancy and gut health What can fingernails tell us? Nutrients and claims about preventing or reversing disease What can the tongue reveal? What can the face reveal? Section 2: Evidence-Based Debrief Do we need exactly 60 minerals, 16 vitamins, 12 amino acids and 3 essential fatty acids? Is Type 1 diabetes created during the first trimester? Can Type 1 diabetes develop later in life? Can maternal nutrition reverse Down syndrome in utero? Peanuts, mold, aflatoxins and liver risk Peppermint essential oil during pregnancy Are Americans “undersalted”? Pharmaceuticals, synthetic drugs and side effects Cholesterol, dietary oils and reproductive health Traditional vs. licensed naturopaths Danielle’s takeaway About Dr. Randi ShannonRandi Shannon, ND, is a Florida-based traditional naturopath known for her use of Face, Tongue and Nail Analysis. She works with clients virtually in Florida, across the United States and internationally.Learn more:TheBodyCan.comRandiShannon.com/face-tongue-nail-analysis/(844) 275-1056About the HostDanielle Plummer, PharmD, is a pharmacist, antepartum doula, and founder of Obstet-Rx. Also known as HG Pharmacist, she helps women navigate Hyperemesis Gravidarum and medication use in complex pregnancies through education, advocacy and personalized medicine.HGPharmacist.comLinkedIn: linkedin.com/in/daniellerplummerHG Support Group: facebook.com/HGClinicalSolutionsImportant Listener NoteThis episode contains health and medical claims made by a guest that may differ from or contradict current evidence-based medical guidance. The guest’s statements represent her perspectives and should not be interpreted as endorsement by MaternalRx, Danielle Plummer, or the Pharmacy Podcast Network.The second half of the episode provides Danielle’s evidence-based commentary on several of these claims.This podcast is for educational purposes and is not a substitute for individualized medical care. Patients should discuss medications, supplements, herbal products, essential oils, and other treatments with an appropriately qualified healthcare professional.   TzrIckmic7Yeigg0uagt

Many pharmacy leaders focus on legislation and lobbying. Why is strategic communication on social media equally important?

In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for providers and specialty pharmacies. Nico shares how Develop Health's AI-native workflows now support over 3 million patients, boosting submission and first-pass approval rates while keeping providers in control every step of the way. Listeners can expect to learn how pharmacies can get started overnight, plus a special offer for NASP members.

Pharmacists and Advocacy for Patients in Pain  Friday, August 21, 2026 What happens when patients living with chronic pain, their advocates, and the pharmacists responsible for dispensing opioid medications view the same healthcare system from very different perspectives? This special episode of This Week in Pharmacy brings together the Doctor Patient Forum’s founders, Claudia A. Merandi and Bev C. Schechtman, with pharmacist and nationally recognized pharmacy advocate Dr. Shane Jerominski, PharmD—better known as “The Accidental Pharmacist.” The discussion follows a wave of social-media debate surrounding Claudia’s use of the term “Harmacists,” which prompted responses from hundreds of pharmacists who felt the label misrepresented their professional responsibilities and the legal restrictions under which they practice. Rather than allow that controversy to deepen the divide, TWIRx created an opportunity for direct, respectful conversation. The purpose of this episode is to help pain-patient advocates better understand the limits pharmacists face when dispensing opioids—and to identify opportunities for pharmacists and patient organizations to advocate together for safe, compassionate and uninterrupted pain care. Five Legal and Supply-Chain Realities Affecting Opioid Dispensing Pharmacists have a federal “corresponding responsibility.”Under 21 CFR §1306.04, a controlled-substance prescription must be issued for a legitimate medical purpose. Pharmacists share legal responsibility with prescribers for determining whether a prescription is valid. Knowingly filling an illegitimate prescription may expose the pharmacist to federal penalties and professional discipline. Review the federal regulation. Schedule II prescriptions must satisfy strict requirements.Federal law generally requires a valid written or compliant electronic prescription before a Schedule II opioid may be dispensed. Emergency oral prescriptions are permitted only under limited conditions and require prescriber follow-up documentation. Schedule II opioid prescriptions cannot be refilled.Under federal law, every additional dispensing generally requires a new prescription. Partial fills are allowed only under specific circumstances, documentation requirements and time limits. Pharmacists cannot simply extend or refill opioid therapy when a patient or prescriber requests it. State laws add another layer of requirements.Depending on the state, pharmacists may have to verify prescriber authority, review prescription-monitoring information, validate electronic or security-form requirements, confirm identification, document partial fills, or comply with state-specific dispensing limitations. For example, California requires controlled-substance prescriptions to meet defined security and validity standards. California Board of Pharmacy guidance. Wholesaler monitoring can restrict a pharmacy’s opioid supply.DEA-registered distributors must identify and report suspicious controlled-substance orders under 21 CFR §1301.74. National wholesalers therefore operate monitoring programs that may delay, limit or suspend shipments based on ordering patterns, geography, drug mix and internal thresholds. These controls are imposed upstream and can leave a pharmacy unable to obtain medication—even when the pharmacist believes a prescription is clinically and legally appropriate. Review the federal distributor requirements. These examples are not exhaustive. Pharmacists must navigate overlapping federal law, DEA requirements, state pharmacy and controlled-substance laws, prescription-monitoring systems, employer policies, payer rules, wholesaler restrictions and professional standards. Requirements also vary by state and by the circumstances surrounding an individual prescription. The Central Question How can pain-patient advocates and pharmacists move beyond blame and work together to address the policies, supply restrictions, staffing conditions and regulatory pressures th

This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won’t cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what’s happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide.Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they’re compounding peptides.Pharmacists Mutual: https://pmuw.comJoin APC: a4pc.org/joinStay up to date on these topics and more at: a4pc.org/news

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from:   Scott Lake - Rx.co Kaley Lester - Outcomes Nicholas Turos - Cencora Janet Parrish - Adair Drug; Colombia, KY Kaushal Patel - Apollo Pharmacy; Savannah, GA Bianca Bradshaw - Elmore Pharmacy; Red Bluff, CA Zackary Levine - Cencora

Growing your pharmacy doesn't always mean finding new patients. It can also mean making the most of the ones you already serve. In this episode, we're joined by our partners AxeRx and Scriptly to share proven strategies for increasing revenue through stronger patient engagement, expanded services, and smarter use of technology to streamline workflows and free up valuable staff time. Tune in for practical insights you can start putting into action today.

The PBM Reform Podcast, sponsored by APCI, welcomes John Vinson, PharmD, Chief Executive Officer of the Arkansas Pharmacists Association, for a timely conversation with host Greg Reybold about the management of the TRICARE pharmacy benefit.   Express Scripts administers pharmacy benefits for TRICARE, the Department of Defense healthcare program serving more than 9 million active-duty service members, military retirees, and family members. In fiscal year 2023 alone, TRICARE spent more than $8 billion on prescription medications.   Greg and John examine concerns surrounding Express Scripts’ administration of the program, including shrinking pharmacy networks, reduced patient choice, questionable contractor reporting, specialty-drug delivery oversight, and the consequences for independent and rural pharmacies.   A 2025 Government Accountability Office investigation found that:   TRICARE’s minimum network requirement fell from 50,000 to 35,000 pharmacies. The network had approximately 13,165 fewer pharmacies in late 2024 than in late 2022. An estimated 380,000 beneficiaries may have been forced to find another pharmacy. The Defense Health Agency relied heavily on contractor-submitted reports that contained inaccuracies. DHA had not consistently audited the data used to evaluate beneficiary access. GAO’s two corrective recommendations remain open as of August 2026, although DHA has begun adding reporting and auditing requirements.   The episode also addresses higher 2026 prescription copayments. For most non-active-duty beneficiaries, home-delivery copays are now $14 for generic formulary drugs, $44 for brand-name drugs, and $85 for non-formulary medications. At retail network pharmacies, the corresponding 30-day copays are $16, $48, and $85.   Greg and John discuss whether PBM-driven network reductions represent true savings—or simply transfer costs, inconvenience, and access barriers to military families and the community pharmacies serving them.   Key discussion points Express Scripts’ role in administering the TRICARE pharmacy benefit Pharmacy network contraction and beneficiary disruption Access challenges facing rural communities and military families Inaccurate contractor data and insufficient federal oversight Specialty-pharmacy delivery and monitoring concerns Rising 2026 copayments and pressure toward mail order Arkansas’ leadership in challenging PBM vertical integration The need for transparency, accountability, adequate reimbursement, and patient choice   Important clarification: TRICARE is administered by the Department of Defense and is distinct from healthcare and pharmacy services operated by the Department of Veterans Affairs.   Sponsored by APCI — American Pharmacy Cooperative, Inc.   Sources: U.S. Government Accountability Office, TRICARE’s 2026 pharmacy-benefit update, official 2026–2027 pharmacy costs.

Independent pharmacies need partners they can trust—and patients need a prescription-drug system that puts access ahead of profits. In this episode of This Week in Pharmacy, Todd Eury welcomes Rick Seipp, PharmD, President of Value Drug Company, to discuss the importance of choosing a dependable wholesale distribution partner. Following Smith Drug Company’s announced operational transition, Value Drug Company is prepared to help affected independent pharmacy owners evaluate their purchasing, distribution and operational needs while developing an orderly transition that protects continuity of service. For more than 90 years, pharmacist-led Value Drug Company has supported community pharmacies through transparent pricing, dependable distribution, collective purchasing power and programs designed to improve efficiency, growth and profitability. Rick explains how the company will provide transition assistance and regional gatherings where pharmacy owners can speak directly with Value Drug Company leadership. The episode also features a follow-up conversation with patient advocate Bil Schmidtknecht about the continuing fight for Cole’s Act. Named in memory of Bil’s son, Cole, the proposed reforms seek to protect patients from unexpected formulary and coverage changes that can suddenly make essential medications unaffordable. “Patients can’t afford more delays, and lives should never be collateral damage in a profit-driven system,” Bil says. The discussion examines PBM accountability, medication affordability and why families must receive meaningful notice before coverage changes place lifesaving treatments beyond their reach. TWIRx News: Week Ending August 14, 2026 Employers Are Moving Away from the “Big Three” PBMs A new employer survey points to growing disruption in the PBM marketplace. Forty-six percent of surveyed employers reported using a PBM outside CVS Caremark, Express Scripts and Optum Rx—up from 37% the previous year. Employers are increasingly seeking transparent pricing, access to claims data and greater control over prescription-drug spending. Read the Axios report FDA Delays Major iPLEDGE Changes Until November The FDA has postponed implementation of updated iPLEDGE REMS requirements from August 8 to November 15, 2026, to allow additional system testing. The forthcoming changes are intended to reduce burdens on patients, pharmacists and prescribers while maintaining safeguards surrounding isotretinoin. Read the FDA iPLEDGE update   Episode Resources Value Drug Company transition-support announcement Value Drug Company transition assistance: 1-866-226-1772 Patient Protector Modern Medical Mafia: PBM Reform Pharmacy Podcast Network About the Guests Rick Seipp, PharmDPresident, Value Drug Company Bil SchmidtknechtPatient advocate and father of Cole Schmidtknecht

Welcome to the 2026 Cencora ThoughtSpot Rewind, sponsored by Outcomes!   In this special 4-part series we get a deep look into the event that took place this year in Orlando Florida. The Pharmacy Podcast Network was embedded into the Outcomes booth where we caught all the action on the show room floor. To learn more about what Outcomes is doing for pharmacies, visit https://www.outcomes.com/   In this episode hosted by Todd Eury, Founder and CEO of the Pharmacy Podcast Network, we hear from: Ross Frei - Outcomes Ana Jimenez - Farmacia Las Americas, West Palm Beach, FL Todd Pendergraft - Broken Arrow Family Drug APA, Broken Arrow, OK Justin Erro - Medzoomer Nick DeSouza - Outcomes Jevic Dunn - Outcomes

In the first episode of this three-part CurifyLabs Podcast Series, we provide a broad overview of the CurifyLabs platform and its role in modernizing personalized medicine and pharmaceutical compounding. The discussion explores how the platform combines digital workflows, automated production technology, and standardized processes to help pharmacies and healthcare organizations improve efficiency, consistency, quality, and scalability.   Listeners will learn how CurifyLabs supports the preparation of customized medications while helping pharmacy teams reduce manual complexity, strengthen documentation, and expand access to patient-specific therapies. This opening episode establishes the foundation for the series and examines how technology can help transform the future of pharmaceutical compounding.

This was one of the most special podcast episodes I’ve recorded todate, especially since it was the first time it was recorded LIVE! Wegathered for GALILEA's Gathering — an intimate evening that broughttogether clinicians, researchers, founders, and facilitators for areal conversation about the future of women's health. I had theprivilege of recording a live interview with neuropharmacologist andGALILEA creator Stephanie Karzon right there in the room, surroundedby people who are genuinely building something newA core focus of our conversation was mapping out why hormones and lifestages are important to factor into female care and why they'reespecially needed for the psychedelic experience, from a biochemicalperspective and for the lived experience.A psychedelic-informed lens in women's care has now becomenon-negotiable; since clients will likely explore these medicines withor without capable practitioners willing to guide them. And let’s faceit, current pharmacotherapy isn't enough. Identity and spiritualitymatter in clinical practice. We need to bring hormone and cycleawareness into practice, as well as the relationship between estrogen,serotonin, glutamate, and psychedelic medicine.Stephanie Karzon Abrams is a clinical neuropharmacologist, founder ofBeyond Consulting—powering the integrative and psychedelic medicinespaces by bridging emerging research with clinical practice, anddesigning clinics and healing centers from the ground up.She serves as Clinical Director at Mystic Health, is an associatedprescriber of MDMA and psilocybin therapy under Canada’s SAP, and isthe Research Director at the Microdosing Collective non profit.Stephanie believes in the undercurrent of joy and authenticity woveninto the fabric of our existence, and thus creates talks and workshopswhere the human experience is explored through the lenses of science,culture, and celebration.With experience in neurology, intensive care, and medical devices atJohnson & Johnson, she is a recognized leader in innovativehealthcare. Her work bridges neuroscience, women’s health, plantmedicine, and the healing power of music. A musician, writer, andspeaker, Stephanie also builds community through gatherings rooted inmusic and meaning through her label Public Secret.Connect with Stephanie via:Email: stephaniekarzon@gmail.comWebsite: Beyond Consulting, Stephanie Karzon Abrams, Galilea HealthIG: @steph__k, @galileahealthLinked In: Beyond ConsultingWhatsApp: galileahealth.communityYouTube: Stephanie Karzon AbramsGift: Womens Health Toolkithttps://drive.google.com/drive/folders/1eiNj8zAaHlPK3CZPLdqh2QInmDrGbCQ2?usp=drive_linkVisit https://marinabuksov.com for more holistic content.Music from https://www.purple-planet.com.Disclaimer: Statements herein have not been evaluated by the Food andDrug Administration. Products listed are not intended to diagnose,treat, cure, or prevent any diseases.

In this episode of the NASP Podcast, Sheila Arquette, R.Ph., President & CEO of the National Association of Specialty Pharmacy (NASP), sits down with Dr. Caroline Girardeau, PharmD, MBA, PMP, BCPS, Pharmacy Program Director at the Accreditation Commission for Health Care (ACHC), to explore the evolving specialty pharmacy accreditation landscape. Together, they discuss the scope and value of comprehensive specialty pharmacy accreditation, examining how rigorous accreditation standards help improve patient safety, clinical outcomes, operational excellence, and the overall quality of care. They also highlight how specialty pharmacies can leverage accreditation as more than a requirement for participation in payer or limited distribution networks, using it as a strategic framework to drive continuous quality improvement, strengthen operations, and elevate the patient experience.

What happens when patients living with chronic pain do not have a pain pharmacist on their healthcare team? In this episode of This Week in Pharmacy, we explore the hidden clinical, emotional, and financial costs of managing pain without a pharmacist trained in pain management. These pharmacists do far more than review medications—they serve as accessible patient advocates, medication experts, care coordinators, and trusted partners for people navigating the complexities of chronic pain. Segment One: Pharmacists Are the Secret Weapon in Pain Management Special guest host Dr. Sing Ping Chow, PharmD, BCPMP, is joined by Dr. Matthew Hermenau, PharmD, BCPMP, CPh, NBC-HWC, CPT, for an important discussion about pharmacist-led pain management. Together, they examine how pain pharmacists can: Identify medication-related risks and opportunities to improve therapy Help patients balance pain relief, function, safety, and quality of life Collaborate with prescribers and other members of the healthcare team Support individualized, evidence-informed treatment plans Educate and empower patients living with chronic pain Advocate for patients whose concerns may otherwise go unheard Address the whole person—not simply a diagnosis or pain score The conversation reinforces a powerful message: pharmacists are one of healthcare’s most underused resources in chronic pain care. When a pain pharmacist is part of the team, patients gain a knowledgeable advocate who understands medications, listens to their lived experiences, and helps them pursue safer and more effective care. Remembering Dr. Jeffrey Fudin This episode includes a special tribute to the late Dr. Jeffrey Fudin, PharmD, widely regarded as pharmacy’s godfather of pharmacist-led pain management. Dr. Fudin was a pioneering clinician, educator, author, mentor, and tireless advocate for the meaningful inclusion of pharmacists in pain care. His work challenged conventional thinking, elevated the role of the pharmacist, and helped build a path for future generations of pain-management specialists. His influence continues through the pharmacists he mentored, the patients he championed, and the profession he inspired. We honor Dr. Fudin’s legacy and his unwavering belief that people living with pain deserve informed, compassionate, and individualized care. Segment Two: The Nation’s Best Hospital Systems In the second segment, we welcome Chelsey Wen, Senior Health Data Analyst with U.S. News & World Report, to discuss the newly released 2026–2027 Best Hospitals rankings. Chelsey explains how U.S. News evaluates hospital performance and how patients and families can use the findings when making healthcare decisions. The latest assessment evaluated nearly 4,500 hospitals across 14 adult specialties and 23 procedures and conditions. It places increased emphasis on patient outcomes and introduces regional specialty rankings designed to help patients locate complex care closer to home. Explore the 2026–2027 Best Hospitals announcement. link: https://health.usnews.com/best-hospitals Topics include: What it means for a hospital to be nationally ranked or rated “High Performing” The clinical data and patient outcomes considered in the evaluation Changes to the 2026–2027 rankings and methodology The importance of regional rankings and access to specialized care How patients should interpret hospital rankings when choosing where to receive care Sponsored By Today’s episode of This Week in Pharmacy is brought to you by First Databank and Outcomes, pharmacy-technology organizations supporting safer, smarter, and more connected healthcare.

Welcome to SuiteCast, a new podcast sponsored by SuiteRx Pharmacy Technology Platforms, exploring the strategies, technologies, and leadership practices helping pharmacies improve performance, expand patient care, and build sustainable revenue.   In this episode, we speak with Betsy P. Reynolds, PharmD, Director of Pharmacy Consulting and Partner at Method Healthcare, and Rodney Whittington, CEO and Partner at Method Healthcare.   Betsy and Rodney discuss how pharmacy leaders can identify operational inefficiencies, strengthen internal workflows, and develop clinical care programs that support both better patient outcomes and business growth. The conversation also examines new revenue opportunities within long-term care, geriatric pharmacy services, and pharmacy consulting.   Listeners will hear practical insights on evaluating current pharmacy operations, implementing scalable clinical programs, improving staff productivity, and aligning technology with the pharmacy’s strategic goals.   Key Discussion Topics Identifying and correcting operational inefficiencies Building sustainable clinical care programs Creating new revenue through pharmacy consulting services Expanding into long-term care and geriatric pharmacy Improving workflow, staffing, and organizational performance Using pharmacy technology to support growth and patient care Preparing pharmacies for changing reimbursement and service models Featured Guests   Betsy P. Reynolds, PharmDDirector of Pharmacy Consulting and PartnerMethod Healthcarebreynolds@methodhc.com   Betsy Reynolds is an experienced pharmacy consultant who helps organizations improve pharmacy operations, develop clinical services, and implement strategies that strengthen financial and patient-care performance.   Rodney WhittingtonCEO and PartnerMethod Healthcare   Rodney Whittington provides strategic leadership and operational expertise to healthcare organizations seeking to improve performance, expand services, and develop sustainable models for growth.   Learn more about Method Healthcare at methodhc.com.   About SuiteCast   SuiteCast, sponsored by SuiteRx Pharmacy Technology Platforms, features pharmacy leaders, technology innovators, and industry experts discussing the tools and strategies shaping the future of pharmacy operations and clinical care.

Vaccines are a key part of an independent pharmacy and clinic's business, but many owners may not be aware of purchasing options, savings opportunities, and ways to maximize their impact. In this episode, Amanda from Vaccine Connect joins us to share insights on all things vaccines, including tips for optimizing your vaccine program and marketing immunizations year-round—not just during flu season.

In this episode of Insights Beyond the Counter, hosts Shane Hallengren and Amit Patel unpack the rapidly evolving world of health risk assessments (HRAs) and social determinants of health (SDOH) across Medicaid and Medicare. Fresh off the Medicaid Innovations Forum, Amit shares insights from health plan leaders navigating a post–Public Health Emergency landscape defined by redeterminations, workforce shortages, and persistent challenges with member contactability. Shane reflects on his years supporting Medicare performance programs and draws parallels between the two sectors—especially around how HRAs have shifted from simple “check‑the‑box” tasks to powerful tools that uncover transportation barriers, food insecurity, medication access challenges, utility instability, and more. Together, they explore: Why SDOH data is only valuable when it leads to meaningful action How community pharmacies—as trusted, accessible care touchpoints—are uniquely positioned to conduct sensitive assessments The growing importance of rural health transformation and how pharmacies can close engagement and adherence gaps How Outcomes is supporting pharmacies with technology, workflows, and scalable programs that enable efficient, person-to-person care What the future may hold as Medicaid and Medicare strategies continue to evolve If you’re passionate about healthcare innovation, population health, or the expanding role of pharmacy, this conversation is packed with real-world insights you won’t want to miss.

This is part 2 of my interview with George Wiseman, where we discuss Brown’s Gas in applications such as Fuel Saving, Torch-Fuel Gas and Radioactive Neutralization (Part 1 all about the health benefits here).We explore how Brown’s Gas:1. neutralizes radioactive waste right at the reactor, 2. can literally make precious stones and metals from rocks, 3. reduces carbon-fuel consumption by 25% or better, 4. helps make your OWN torch-fuel, 5. helps plants grow up to 10x FASTER,6. can make Deuterium Depleted Water ,7. helps bodies heal from virtually every ailment known to man, 8. helps wounds heal 3x faster,9. optimizes health and performance, AND best of all…this technology can be made using WATER in your OWN HOME! George Wiseman is an inventor, engineer, and founder of Eagle-Research, best known for his decades of work developing Brown’s Gas technology for both energy and emerging wellness applications. Raised as a rancher’s son in a remote, off-grid environment, George learned early how to build, repair, and survive with limited resources, which influenced his lifelong commitment to practical and reliable innovation.After leaving the ranch in the late 1970s, he pursued a path in alternative energy and automotive systems, eventually specializing in fuel efficiency and combustion technologies. In the 1980s, he began developing Brown’s Gas systems that could significantly improve fuel economy and even replace traditional torch gases at a fraction of the cost.Over time, George’s work took an unexpected turn as customers began reporting potential health-related effects from the technology—something he initially dismissed. Years later, after personally experimenting with the applications and witnessing growing anecdotal results, he shifted his focus toward exploring its broader potential and developed his at-home device, AquaCure.This mission became deeply personal following the loss of his wife after a long battle with Lupus, which intensified his commitment to sharing what he had learned. Today, George is driven by a singular goal: to make his technology accessible to as many people as possible.Connect with George via:Email: wiseman@eagle-research.comWebsite: https://eagle-research.com/, https://www.aquacure.life/FB: https://www.facebook.com/profile.php?id=100054308450085IG: https://www.instagram.com/georgewiseman1984/LinkedIn: https://www.linkedin.com/in/george-wiseman-53969814/X: https://x.com/Eagle_ResearchYT: https://www.youtube.com/@ecopegasus

PBM Reform PodcastSponsored by American Pharmacy Cooperative, Inc. (APCI)Host: Greg ReyboldSpecial Guest: Ben Mudd, PharmD, Executive Director, Kentucky Pharmacists Association   Momentum for meaningful pharmacy benefit manager reform is building in Washington.   In this episode of the PBM Reform Podcast, host Greg Reybold welcomes Dr. Ben Mudd, Executive Director of the Kentucky Pharmacists Association, to examine the bipartisan Pharmacists Fight Back Act, H.R. 6610, and what its advancement could mean for patients, pharmacists, employers, and the future of independent pharmacy.   On July 22, 2026, the House Committee on Oversight and Government Reform reported the legislation favorably following a committee markup. Introduced by Chairman James Comer of Kentucky and Representative Jake Auchincloss of Massachusetts, the bill would establish new requirements for pharmacy benefit managers participating in the Federal Employees Health Benefits Program.   The proposed reforms would require participating PBMs to provide fair pharmacy reimbursement, apply manufacturer rebates toward reducing beneficiaries’ prescription drug costs, prohibit patient steering to PBM-affiliated pharmacies, increase transparency, and establish penalties for noncompliance.   Greg and Ben discuss why the Federal Employees Health Benefits Program could become an important proving ground for broader PBM accountability and how federal action may influence commercial plans, state legislation, and future healthcare policy.   Episode Discussion   The conversation explores:   Why H.R. 6610 has attracted bipartisan support How PBM reimbursement practices threaten independent pharmacy sustainability The impact of patient steering and PBM-affiliated pharmacy networks Why manufacturer rebates should directly reduce patients’ prescription costs What “fair reimbursement” must include to protect pharmacy access How enforcement provisions and financial penalties could improve accountability Kentucky’s role in advancing pharmacy and PBM reform The connection between federal legislation and state-level advocacy What pharmacists should communicate to legislators and patients The remaining steps required before H.R. 6610 can become law   Dr. Mudd brings the perspective of a practicing community pharmacist and association executive who has worked extensively in pharmacy advocacy. A graduate of the University of Kentucky College of Pharmacy, he practiced in both chain and independent pharmacy settings before assuming leadership of the Kentucky Pharmacists Association.   Ben is running for Kentucky State Senate position this November. Lear more about his platform and issues most important: https://www.votemudd.com/meet-ben   Key Takeaway   PBM reform is no longer simply an industry debate. It is a patient-access, healthcare-affordability, pharmacy-choice, and community-infrastructure issue.   The Pharmacists Fight Back Act represents a significant federal effort to separate PBM compensation from practices that may increase drug costs, restrict patient choice, and financially disadvantage independent pharmacies. The legislation’s advancement is an important milestone—but pharmacists must remain informed, engaged, and vocal as the bill moves through the legislative process.   Subscribe to the PBM Reform Podcast for continuing coverage of legislation, regulation, litigation, and advocacy shaping the future of pharmacy benefit management and community pharmacy.   The PBM Reform Podcast is sponsored by American Pharmacy Cooperative, Inc., supporting independent pharmacies and advocating for a more transparent, competitive, and patient-centered prescription drug marketplace.

Psychedelics, hallucinogens, natural medicines, you name it, we’re covering it on this episode of the Pain Pod folks! We’ll chat through all types of psychedelics including LSD, MDMA, Psilocybin, DMT, and Ketamine and beyond. No trippin’ just learnin’!You’re not going to want to miss this one!Come one, come all, to the Pain Pod!!!Pain Guywww.painguy.us

The Independent Pharmacy Cooperative is partnering with Fullscript to help independent pharmacies expand their wellness offerings without adding inventory, storage costs, or fulfillment responsibilities.   Through the partnership, IPC members receive free access to Fullscript’s digital platform, featuring more than 375 trusted supplement brands. Pharmacies can recommend personalized wellness protocols, earn approximately 35% margins on online sales, and benefit from direct-to-patient shipping, automated refill reminders, and optional auto-ship services.   Fullscript manages product inventory, payment processing, and delivery, giving independent pharmacies a practical way to generate recurring revenue while supporting patient adherence and long-term wellness goals.   Guests:   Kelli - IPC Christopher - FullScript Shannon - IPC Andrea - Pharmacy Owner Emlah Tubuo - Pharmacy Owner

In this episode, host Jon Grice takes a candid and timely look at the evolving role of Medication Therapy Management (MTM) in community pharmacy. Jon raises an important question: Are pharmacists missing a critical opportunity hiding in plain sight?He explores why MTM remains essential—not just for patient care, but for the financial sustainability of today’s pharmacies. He discusses the shifting landscape where dispensing margins have eroded, clinical services have become the new value driver, and yet emotional and historical frustrations with payers may be holding some pharmacists back from embracing what’s next.Drawing on conversations with industry leaders and his own lived experience as an independent pharmacist, Jon challenges listeners to re‑examine assumptions, recognize cognitive biases, and reconnect with the shared goals of insurers, pharmacies, and patients.Whether you're a chain pharmacist, an independent owner, or someone trying to understand the future of clinical care, this episode offers a grounded, honest look at where MTM stands—and where it needs to go next.

Chris Antypas, PharmD and President of Asti’s South Hills Pharmacy in Pittsburg, PA, along with his partners are launching Medesto Heath.  This totally new type of technology will allow pharmacist to combine prescription data, lab results, clinical notes and other health metrics and determine if the medications a patient is taking are actually working.  This is way more than adherence and MTM.  It is a totally new paradigm for pharmacy care.  Antypas is joined by Robyn Amberg who has known Antypas for several years and proposed this podcast.

Independent pharmacies are facing growing reimbursement uncertainty, especially when dispensing high-cost brand medications such as GLP-1 therapies. In this exclusive Pharmacy Podcast Network special feature, we examine how GoodRx Community Link provides independent pharmacies with predictable pricing and favorable economics across both brand and generic medications, ultimately helping pharmacies remain solvent while providing consumers affordable prescription prices.   Todd Eury is joined by David Graziano, Head of Retail Network at GoodRx, and Tom DePietro, independent pharmacy owner at DePietro’s Pharmacy, for a practical discussion about the pressures affecting independent pharmacy and the need for reimbursement models that support  pharmacy viability. The conversation explores how Community Link supports brand medications through manufacturer-funded savings that flow back to the pharmacy through GoodRx, while the manufacturer covers the administrative fee. For generic medications, the program uses a NADAC-based cost-plus model intended to provide clearer visibility into reimbursement. Listeners will also hear how independent pharmacies are impacted by rising deductibles, prior authorizations, narrow formularies, cash-pay growth, and increased competition. David and Tom discuss the importance of transparent pricing, digital engagement, streamlined fulfillment, personalized patient care, and sustainable economics for local pharmacies. Key discussion points include: The financial risk of dispensing high-cost brand medications like GLP-1s Predictable reimbursement for brands and generics The role of manufacturer-funded savings for brand medications NADAC-based cost-plus pricing for generics Pharmacy access to GLP-1 cash-pay programs Competing through service, technology, and patient relationships Protecting local healthcare access through independent pharmacy Explore how GoodRx Community Link can bring greater transparency and predictability to brand and generic dispensing, helping independent pharmacies serve patients sustainably and with confidence. Featured Guests: David Graziano — Head of Retail Network, GoodRx Tom DePietro — Independent Pharmacy Owner, DePietro’s Pharmacy Host: Todd Eury — Founder, Pharmacy Podcast Network Visit goodrx.com/CommunityLink to learn more GoodRx is NOT insurance.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to AAPA, for sponsoring this coverage! In this episode we hear from: Kate Helf - IPC Nancy Lyons - McKesson Mackenzie Hernandez - NimbleRx Mohan Gulati, CEO - Thinkrr.ai Ryan Spaulding, VP Sales - Lumistry Veronica German - McKesson Alex Berce - Good Value Pharmacy Crystal Lennartz, President - Health Mart & Health Mart Atlas Kerolos Ekladious - TJM Labs Marc Essensa, CEO - IPC

In this episode, host Ross Frey, Senior Product Manager and resident MTM/CMR strategist, sits down with Cindy Henry, Director of Payer Products at Outcomes, to unpack one of the biggest changes hitting Medicare Advantage plans: CMS’s intent to return the CMR completion rate to the Star Ratings program beginning in measure year 2027.Ross and Cindy explore how the industry reacted to the latest CMS Advance Notice, why the CMR measure’s return matters, and how MTM strategy has quietly shifted during its two‑year placement on the display page. Together, they outline the pressures plans are feeling—from shrinking margins to rising expectations around clinical quality—and the renewed focus on the value of medication therapy management, total cost of care, and local pharmacy engagement.A key topic throughout the episode is the impact of CMS’s expanded MTM eligibility criteria, which significantly increases denominators for 2025 and beyond. Cindy explains how this shift forces payers to rethink scale, budget, ROI, and operational models, while Ross shares Outcomes’ cut‑point predictions and how performance is likely to redistribute once the measure becomes active again.The conversation also highlights Outcomes’ strategy to support both health plans and community pharmacies as they prepare for 2027. Ross describes work underway to reduce documentation burden, streamline workflows, leverage new technology, and allow pharmacists to practice at the top of their license—ultimately helping MTM delivery scale without sacrificing quality.By the end of the episode, the message is clear: Plans that begin modeling, staffing, vendor alignment, and workflow modernization now will be best positioned when Star Ratings recalibrate in 2029. Listeners are encouraged to explore Outcomes’ latest prediction models and analysis at outcomes.com

I was blown away by my conversation with today’s guest, who discovered that without HEALTH you have nothing... He became a Jack Of All Trades and subsequently an inventor that has changed entire venues with his innovations. He has fully recovered his health thanks to one of his own inventions, and is now on a mission to help people optimize their health to enjoy living!George Wiseman is an inventor, engineer, and founder of Eagle-Research, best known for his decades of work developing Brown’s Gas technology for both energy and emerging wellness applications. Raised as a rancher’s son in a remote, off-grid environment, George learned early how to build, repair, and survive with limited resources, which influenced his lifelong commitment to practical and reliable innovation.After leaving the ranch in the late 1970s, he pursued a path in alternative energy and automotive systems, eventually specializing in fuel efficiency and combustion technologies. In the 1980s, he began developing Brown’s Gas systems that could significantly improve fuel economy and even replace traditional torch gases at a fraction of the cost.Over time, George’s work took an unexpected turn as customers began reporting potential health-related effects from the technology—something he initially dismissed. Years later, after personally experimenting with the applications and witnessing growing anecdotal results, he shifted his focus toward exploring its broader potential and developed his at-home device, AquaCure.This mission became deeply personal following the loss of his wife after a long battle with Lupus, which intensified his commitment to sharing what he had learned. Today, George is driven by a singular goal: to make his technology accessible to as many people as possible.

Specialty pharmacy is becoming one of the most important access points in modern healthcare, particularly for patients managing complex, chronic, rare, and high-cost conditions. As therapies advance and patient needs become more sophisticated, health systems are rethinking how specialty pharmacy can improve medication access, continuity of care, clinical outcomes, affordability, and the overall patient experience.   In this special episode of This Week in Pharmacy, the Pharmacy Podcast Network introduces Specialty Care Close to Home, a new series examining how hospitals and health systems are designing, building, supporting, and scaling specialty pharmacy services across health-system and community-based care models.   Featured Guests   Dr. Laura Mark, PharmDVice President of Pharmacy, Allegheny Health Network   Allison ArantSenior Vice President, Clearway Health   Chris CorsiChief Executive Officer, CassianRx   Together, the guests discuss why health-system specialty pharmacy expansion matters, what successful programs require, and where the greatest strategic and operational challenges exist. The conversation explores how strong partnerships, integrated clinical workflows, patient-centered technology, and coordinated care teams can reduce fragmentation and improve specialty medication access.   Discussion Highlights The growing strategic role of health-system specialty pharmacy Keeping patients connected to trusted local care teams Improving access, adherence, affordability, and therapy management Building scalable specialty pharmacy infrastructure Integrating clinical, operational, and technology capabilities Overcoming payer, workflow, workforce, and reimbursement challenges Creating collaborative models that support long-term sustainability   Future episodes of Specialty Care Close to Home will explore accreditation, payer access, manufacturer relationships, clinical workflow, patient engagement, technology infrastructure, data reporting, community access, workforce development, and financial sustainability.   The series will also feature pharmacy directors, vice presidents, executives, operators, and innovators from health systems across the country who are leading the next generation of specialty care delivery.   Host: Todd Eury, Founder of the Pharmacy Podcast Network   Coming Soon: Specialty Care Close to Home—a national conversation about bringing advanced specialty pharmacy services closer to where patients live, work, and receive care.

Switching pharmacy management software is one of the biggest decisions an independent pharmacy can make, and one of the most disruptive if done incorrectly. In this episode of Insights Beyond the Counter, we discuss the real considerations behind changing pharmacy management systems: wh y pharmacies decide to switch, what holds them back, and what makes a transition successful. From workflow challenges and data migration concerns to staff training and long-term scalability, this conversation provides practical insight for pharmacy owners evaluating their current system. If you’re frustrated with inefficiencies, limited support, outdated technology, or lack of growth tools, this episode will help you better understand what to evaluate before making a move. In   This Episode: • Signs it may be time to consider a new pharmacy management system • Common fears around switching software • What a smooth implementation process should look like • How to minimize workflow disruption during transition • Why long-term partnership and support matter more than price   This is an audio-only episode. Listen in while you work, drive, or catch up between scripts.   To learn more about our Pharmacy Management Software, check us out at https://www.outcomes.com/. For demo, click here: https://www.outcomes.com/request-a-ph...

AI in Pharmacy Standards and Drug Supply Chain UpgradesThis Week in Pharmacy — July 17, 2026   Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations.   In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access.   Guests   Shawn Griffin, MDPresident and CEO, URAC   Brent WilhelmSenior Vice President, Global Supply Chain Center of Excellence, Cencora   Tim WeberPharmacy Operations and Regulatory Executive   AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale.   The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.   Governance and accountability for AI outputs Human review of AI-supported decisions Monitoring safety, accuracy, and bias The role of accreditation in AI oversight Balancing innovation with patient protection   Drug Availability Versus Patient Access   Brent Wilhelm of Cencora discusses why a medication may exist somewhere in the supply chain but still remain difficult for providers to obtain.   Dosage limitations, delivery timing, ordering complexity, reimbursement barriers, cold-chain requirements, and site-of-care restrictions can all delay patient access.   Wilhelm explains why the industry must look beyond inventory levels and focus on whether providers can obtain the correct therapy, at the right location, when the patient needs it.   Inventory visibility versus actual access Differences across pharmacies and sites of care Specialty and temperature-sensitive therapies Provider demand forecasting Reducing delays, shortages, and waste   Tim Weber adds the pharmacy operations and regulatory viewpoint, discussing inventory planning, compliance, product tracing, reimbursement, and patient fulfillment.   The conversation highlights the need for better coordination among manufacturers, distributors, pharmacies, health systems, payers, and regulators.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends. Thank you to Independent Pharmacy Cooperative (IPC), for sponsoring this coverage In this episode we hear from: Timothy Lawson Metropolis Drugs & IPC Member John Covello Chris Darling - Darling Apothecary Ollin Sykes - Sykes and Company Diana Baumohl - Go Mango Meds Sam Pizzo - LSPedia Emlah Tubuo - Emlah Consulting

In this episode, Andrew Kantor is joined by federal lobbyist David Pore and PCCA's Amy Shank to examine the proposed SAFE Act and its potential impact on compounding pharmacies. The discussion explores concerns that the bill could restrict patient access to compounded medications during drug shortages, impose new limitations on 503A pharmacies, and disproportionately affect legitimate compounders while failing to address bad actors. The episode also unpacks the legislation's connection to GLP-1 demand, adverse event reporting, and the bipartisan politics surrounding the bill, while encouraging listeners to stay engaged in APC's advocacy efforts.

Welcome to Insights Beyond the Counter, a podcast exploring the forces shaping pharmacy today — from technology and operations to reimbursement, policy, and what it all means for the people behind the counter.    In this episode, we dig into: • The realities independent pharmacies are facing right now • How data, workflow, and smarter systems can drive better outcomes • What’s changing — and what isn’t — in the pharmacy ecosystem   This is an audio-only episode. Listen in while you work, drive, or catch up between scripts.   To learn more about our Pharmacy Management Software, check us out at https://www.outcomes.com/. For demo, click here: https://www.outcomes.com/request-a-ph...

Integrative Care Impact and the Expanding Role of the Pharmacist | TWIRx Today’s episode of This Week in Pharmacy explores two major opportunities shaping the future of the profession: the growth of holistic and integrative pharmacy services inside community pharmacies, and the expanding demand for pharmacists across the business, insurance, and PBM sectors. In our first segment, Todd Eury welcomes special guests Robert Kress, RPh, and Dr. Bianca Bradshaw, PharmD, owner of Elmore Pharmacy in Red Bluff, California. Together, they discuss the tremendous opportunity for independent pharmacies to build holistic and integrative health departments that respond to growing consumer demand for natural products, supplements, wellness solutions, and personalized care. Dr. Bianca Bradshaw, PharmD https://www.linkedin.com/in/bianca-bradshaw-141092205/ Patients are increasingly seeking more natural approaches to health, but they still need trusted clinical guidance. Community pharmacists are uniquely positioned to help patients evaluate products, avoid harmful interactions, understand evidence, and develop safer, more effective wellness plans. This conversation explores how pharmacies can create new service lines, improve patient relationships, and establish sustainable revenue opportunities through integrative care. In our second segment, Dr. Bonnie Hui-Callahan, PharmD, returns to the show to discuss career opportunities for pharmacists within Judi Health and Capital Rx, as well as the broader business and insurance side of pharmacy. Dr. Bonnie Hui-Callahan, PharmD https://www.linkedin.com/in/bonnie-hui-callahan/ As PBMs continue to evolve, new-generation models are creating demand for pharmacists who understand clinical care, benefits, formulary strategy, patient access, data, and healthcare economics. Bonnie shares why pharmacists will remain essential as PBMs transform and why the profession should look beyond traditional dispensing and clinical practice roles when considering future career paths. Today’s episode is sponsored by Independent Pharmacy Cooperative and SuiteRx. Listen to This Week in Pharmacy on the Pharmacy Podcast Network.

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered. McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy. Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to AAPA, for sponsoring this coverage!   In this episode we hear from: Kelli Sneed & Shams Shibley - AAPARx John Covello with IPC and Anne Cassity with NCPA Mike Bollinger - LiveOak Bank Shahida Choudhry & Jake Johnson - Palms Pharmacy Blair Thielemier - PQS by Innovaccer Nick Fournarakis - Fagron

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Santana VanDyke, MD, Assistant Professor of Dermatology and Director of the Hidradenitis Suppurativa Clinic at University of Vermont Health, and Ryan Lackey, PharmD, CPPS, Ambulatory Pharmacist Clinician and Co-Director of the clinic. They discuss Hidradenitis Suppurativa (HS), including disease presentation, treatment options, emerging therapies, and research currently underway. The conversation highlights UVM Health’s collaborative care model that brings together dermatology and specialty pharmacy to improve the patient experience and clinical outcomes.

What does it actually take to modernize a independent pharmacy chain with 25+ locations without overwhelming your team? Kathy Collier, Regional VP of Operations at ExpressRx, and Scott Von Deylen, VP of Sales at Nimble, join host Todd Erie to answer that question.Kathy shares how ExpressRx partnered with Nimble to deliver a digital patient experience patients genuinely enjoy using, while keeping operations lean and compliant. If you're a pharmacy operator trying to compete on convenience without adding complexity, this episode shows exactly what the right technology partnership can unlock.

Today e celebrate 250 Years of Freedom during this 4th of July special with Scotty Sykes with Sykes & Company Pharmacy Accounting Experts. Next, a special interview with Virginia Halsey SVP of Strategy and Product Management and Brad Engels Product Manager at First Databank (FDB).  Today's TWIRx is sponsored by Sykes & Company  250 Years of Freedom - 4th of July Special | TWIRx

This is the Pharmacy Podcast Network's coverage of the 2026 McKesson ideaShare! Missed the big event? We've got you covered.   McKesson's ideaShare is one of the largest community pharmacy brainstorm events. Empowering current and future independent pharmacists with deeper connections, new ways to innovate, and strength in numbers for the voice of community pharmacy.   Join host Todd Eury, CEO of the Pharmacy Podcast Network, as he walks the exhibit hall in Denver Colorado interviewing vendors, attendees, independent pharmacy owners, and industry friends.   Thank you to the Independent Pharmacy Cooperative (IPC), for sponsoring this coverage!   In this episode we hear from:   Mark Kinney - IPC Eddy Sookswat - McKesson Kevin Boesen - Outcomes Nick Secret - IPC Dave Randolph - Dave's Pharmacy Jimmy Pappadeas & David Plotkin - Scripted Samantha Pomeroy - IPC Sallie Rafie - Birth Control Pharmacist

Functional medicine has been on the tip of the tongue and observed online and on social media for years now, more than in the past, but just what is it and how can it help our patients in pain?Dr. Lauren Castle joins us as a dual expert in the realm of functional medicine and psychedelic pharmacy to clear the fog and address any myths out there for all things functional medicine.Come one, come all, to the Pain Pod!!!P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!Guest InfoLauren Castle, PharmD, MS, AFMCFunctional Medicine Pharmacists Alliance, Founder (https://www.fmpha.org/)Psychedelic Pharmacists Association, Founder (https://psychedelicpharmacist.org/)

It was an absolute honor to meet today’s guest, and I was honestly a bit starstruck! She is rooted equally in both the science of food and intuitive eating. We dove into the phytochemistry of nutrients, and most importantly, discussed the fundamental principles for healthy eating.Dr. Deanna Minich, PhD, CNS, IFMCP is a pioneering nutrition scientist and thought leader with over 25 years of experience bridging science, spirituality, and art to redefine holistic health. Internationally recognized for her work on color-coded nutrition (“eating the rainbow”), detoxification, and hormone health, Dr. Minich brings a multidimensional lens to wellness that is both grounded in research and infused with a soulful approach.For over a decade, she worked closely with the “Father of Functional Medicine,” Dr. Jeffrey Bland on R&D and functional medicine education with the Institute for Functional Medicine and assisting with the start-up of the Personalized Lifestyle Medicine Institute (PLMI) and now on the Board for PLMI.In 2025, she was awarded the Linus & Ava Helen Pauling Award by the Institute for Functional Medicine, one of the highest honors in the field, for her groundbreaking contributions to science-backed integrative health.As the Chief Science Officer at Symphony Natural Health, Dr. Minich leads the Science-Medical Team’s innovation in endocrine, metabolic, and circadian health, developing evidence-based approaches that empower people to reclaim vitality through rhythm, root-cause healing, and renewal.A passionate educator and communicator, she develops transformative curricula and continuing education for health professionals, while also creating accessible, inspiring resources for the general public. Her work meets people where they are, whether they’re practitioners seeking clinical precision or individuals seeking a deeper connection to their body’s wisdom.Connect with Dr. Deanna via:Email: info@foodandspirit.comWebsite: Dr. Deanna MinichFB: Deanna Minich, PhDIG: @deannaminichYT: @foodandspiritLinked In: Deanna Minich, PhD, MS, FACN, CNS, IFMCPVisit https://marinabuksov.com for more holistic content.Music from https://www.purple-planet.com.Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

THIS WEEK IN PHARMACYPBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine Presented by SuiteRx Pharmacy Software TechnologiesLearn more at SuiteRx.com Episode Overview On this episode of This Week in Pharmacy, Todd Eury brings together two timely conversations focused on pharmacy transformation, advocacy, clinical education, and the future role of pharmacists in healthcare. First, Todd welcomes Brad Hart, owner of Forest Park Pharmacy, a cash-based independent pharmacy model challenging the traditional reimbursement structure many pharmacies operate under. Brad has become a powerful advocate for pharmacy transparency, using TikTok and social media to expose current PBM practices, share data, and speak directly to patients, pharmacy owners, and policymakers about the realities facing independent pharmacies. Brad’s message is clear: patients deserve transparency, pharmacy owners deserve fair treatment, and the profession needs more voices willing to educate the public with facts and truth. In the second half of the episode, Todd is joined by Dr. Colby Burns and Dr. Andy Krut from the Psychedelic Pharmacists Association. This discussion helps set the groundwork for understanding psychedelics in medicine, the evolving role of pharmacists in psychedelic education, and the clinical potential of psychotropic therapies historically limited by regulation, stigma, and lack of provider education. As interest in psychedelic-assisted care grows, pharmacists must be part of the conversation. Dr. Burns and Dr. Krut explain why pharmacist education, medication safety, and clinical understanding are essential as healthcare explores emerging approaches to mental health, trauma, pain, and complex patient care. Featured Guests Brad HartOwner, Forest Park Pharmacy Dr. Colby BurnsPsychedelic Pharmacists Association Dr. Andy KrutPsychedelic Pharmacists Association Sponsored By This episode of This Week in Pharmacy is brought to you by SuiteRx Pharmacy Software Technologies. SuiteRx provides pharmacy software solutions designed to support independent pharmacies, improve workflow, enhance patient care, and help pharmacy teams operate more efficiently in today’s demanding healthcare environment. Learn more at SuiteRx.com.

Women are driving innovation, improving patient care and leading independent pharmacies through a changing healthcare landscape. In this episode, hosts Jason Callori, Michelle Britt (SVP, Retail Independent, Inside Sales & First Vet Services), and Chelsie Waite (Director of Sales, Retail Independent Sales - West Region) sit down with two remarkable women leaders: Monica Nikseresht, PharmD, and Melissa Hood-Benges, PharmD.   Monica and Melissa share their personal journeys, leadership lessons and insight into key challenges and opportunities. Listen to a conversation highlighting leadership, resilience, advocacy, and innovation, while celebrating women as leaders and change-makers in pharmacy.

What happens when Estrogen and alcohol mix? In this episode we explore how alcohol affects estrogen levels and what every woman should know about drinking during different stages of life.   https://pubmed.ncbi.nlm.nih.gov/10397281/ https://www.mariongluckclinic.com/blog/hormones-and-alcohol-could-reducing-alcohol-help-with-hormone-balancing.html https://news.weill.cornell.edu/news/2024/12/preclinical-study-finds-surges-in-estrogen-promote-binge-drinking-in-females

During the episode, Nicolle and Darshan discuss how marketing for pharmacies has become more challenging especially with GLP-1s, Compounding and AI. They highlight common mistakes pharmacy owners make when marketing their services and how to avoid them.

Today’s guest shares my mission to empower others to take control of their health and address the root cause. We talk about challenges to testing and addressing the foundations of health, which begins with Minerals & Metals.Jeff Lioon is the Creative Director at The Oligoscan. He’s tested over 7,000 people with the device over the last 9 years. After correlating Oligoscan Reports with what people say about their symptoms and health conditions, the test is almost always spot on.I got the opportunity to use scan myself at this year’s Integrative Health Symposium in NYC, and I was really impressed with the report. It gave me a deeper understanding of my baseline and how to optimize my health further, and further decrease exposure to heavy metals.I highly recommend checking out the scan for yourself, and for your clients.Connect with Jeff via:Email: jeff@theoligoscan.comWebsite: The OligoscanIG: @jefflioon, @theoligoscanLinked In: Jeff Lioon

On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation.   First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today’s rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong.   We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare.   Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John’s University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care.   Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice.   Listen to This Week in Pharmacy on the Pharmacy Podcast Network.Pharmacy’s future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Duane Morris Pharmacy Litigation Group Chair, and Bradley A. Wasser, Duane Morris Pharmacy Litigation Group Partner. They discuss the 2026 Consolidated Appropriations Act and its landmark PBM reform provisions that impact pharmacy network access and transparency. These expert litigators go into detail about what specialty pharmacies should expect as federal agencies enforce the new law and what opportunities and challenges lie ahead for specialty pharmacies.

In this episode of The Executive Dose Podcast, host Stephen Beckman leads a timely discussion on how pharmaceutical manufacturers approach portfolio ideation, portfolio development, and strategic growth in today’s increasingly complex healthcare environment.   Stephen is joined by Joe Hendrickson, Head of Strategy and Corporate Development for Serovia, for a conversation focused on how manufacturers identify unmet market needs, evaluate product opportunities, prioritize development pathways, and make strategic decisions amid growing industry pressure.   The discussion explores how pharmaceutical companies move from early-stage ideation to portfolio evaluation, development, commercialization, and lifecycle planning. As manufacturers face rising pricing pressure, market access barriers, regulatory expectations, competitive intensity, supply chain constraints, and evolving stakeholder demands, disciplined portfolio strategy has become more important than ever.   Listeners will gain perspective on how manufacturers are navigating uncertainty, adapting their growth strategies, and building more resilient portfolio models designed to bring meaningful therapies and solutions to market. Special Guest Joe HendricksonHead of Strategy and Corporate Development Serovia

Today’s guest dropped an unbelievable amount of wisdom in the span of just one podcast episode. She and I both align on so many topics as you will discover in our conversation. We both believe that women have the power to intuit what is best for them and their bodies.Women, especially midlife women, have been taught for far too long that their suffering is "just a part of aging." The system has also taught us that when we have symptoms, we should reach for a drug to fix it (and often holistic medicine is thought of as an alternative herb or supplement).My guest asserts that when symptoms arrive for women in midlife and perimenopause, it is often a wake up call to how we are living our lives, particularly the accumulation of not so nourishing choices in the last couple of decades. Hormones shift, revealing what has already been happening. Women can then heed the call to pay attention to foundational living (how they are eating, sleeping, managing energy, stress, etc) and prevent further disease down the road.The common approach to manage symptoms with herbs and/or HRT are only addressing the tip of the iceberg and are not going to get at the root cause of symptoms. Perimenopause and menopause does not have to be a negative life sentence to the rest of your life, rather it can be seen as an initiation and invitation to finally start prioritizing yourself.Maria Gabriela is a certified Ayurveda Health Counselor, a doctor of pharmacy (Pharm.D.), a 200 hour certified yoga teacher, and founder of Intuitive Ayurveda. She helps people in perimenopause and menopause feel better in their bodies using Ayurveda, science-backed tools, and intuitive coaching — so they can celebrate this phase of life instead of dreading it.The eastern and western perspectives of medicine each have something to offer us, and Maria Gabriela understands this dance. Her goal is to educate on Ayurvedic tools that can (and should) be individualized to each complex person.She strives to help her clients tune into the messages their bodies are sending them. Ultimately, she believes every person is the expert on what is best for them, and can be empowered to hone in on which tools they need to support themselves in mind, body, and spirit.Connect with Maria Gabriela via:Email: maria@intuitiveayurveda.comWebsite: Intuitive AyurvedaIG: @intuitive_ayurveda

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part six of our six part series! We'd like to thank Finch Marketing for sponsoring this episode! On this episode we interview: Nicolle McClure - President, Finch Marketing Seth Chaney - CEO, 609 Health Natalie Ryan - Vice President of Specialty Pharmacy Srulik Dvorsky - TailorMed Michael Oleksiw and Abby Reynolds - Pleio Fran Gregory - PharmD, Cardinal Health

This episode we look at some of the latest compounding news, and then we’ve got a deep dive into state-level legislation with the Leading Ladies of Pharmacy Compounding Advocacy.What bills are being introduced? What do they really mean when you read the detail? How will they affect state policies, and what could come next? And, of course, how are APC and compounding pharmacies fighting back against the bad bills that put patients at risk?If you’re a compounder, if you have patients who use compounded medications, or if you’re a patient yourself, you’ll want to hear this.Links from the podcast:The FDA statement on excluding GLP-1s from bulk compounding: https://fllw.me/491oGl3FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C (part 1), https://fllw.me/4nxd13G (part 2)Is It Legit? to find a state-licensed compounding pharmacy: https://a4pc.org/isitlegitJoin APC! https://a4pc.org/join

Birth Rights, Medical Bills & Maternal Advocacy with Andi Orwoll, EsqIn this powerful episode of MaternalRx, Dr. Danielle Plummer sits down with Nevada attorney and founder of Your Legal Doula, Andi Orwoll, to discuss the often-overlooked legal and financial realities families face during pregnancy, birth, and postpartum recovery.From navigating IVF paperwork and unexpected C-sections to battling insurance denials and understanding birth rights, Andi shares how her own journey into motherhood inspired her to create a legal advocacy practice specifically for pregnant and postpartum families.This conversation explores the intersection of maternal health, patient advocacy, legal protections, informed consent, workplace rights, and the emotional toll of navigating the U.S. healthcare system during one of life’s most vulnerable seasons.In this episode, we discuss:- Why birth rights matter- The legal gaps in maternal healthcare- Insurance denials and surprise medical bills- IVF, fertility care, and the hidden administrative burden- Informed consent and patient advocacy during labor- The Pregnant Workers Fairness Act (PWFA)- The midwifery model of care vs. traditional obstetric care- Maternal mental load and postpartum vulnerability- Why tracking medical records, bills, and receipts matters- Navigating medical bills and insurance appealsKey Takeaways:“Policy never overrides your rights.”Andi explains how many patients are intimidated in medical settings and may not realize they have the legal right to informed consent, respectful care, and bodily autonomy during pregnancy and birth.Birth experiences matter.Even when outcomes are medically positive, the emotional and psychological experience of birth can have lasting effects. Advocacy, education, and support can profoundly shape those experiences.The paperwork burden is real.Pregnancy often comes with overwhelming administrative tasks: insurance appeals, billing disputes, maternity leave paperwork, provider reimbursements, and more — all during an emotionally and physically vulnerable time.Midwives, doulas, OBs, pharmacists, and lawyers all have a role.Maternal healthcare works best when it’s collaborative. This episode highlights the importance of interdisciplinary support systems for pregnant families.Track everything.One of the biggest practical pearls from this episode: keep copies of:- Medical bills- Insurance explanations of benefits (EOBs)- Receipts- Appointment dates- Correspondence with insurance companies- Workplace accommodation requestsDocumentation can make all the difference if problems arise later.About the Guest:Andi Orwoll is a Nevada-licensed attorney and founder of Your Legal Doula, a legal advocacy practice focused on supporting families navigating pregnancy, birth, postpartum recovery, workplace accommodations, and healthcare systems in the United States.Inspired by her own experience with IVF, an unexpected hospital birth, and overwhelming postpartum paperwork, Andi created Your Legal Doula to help families understand their rights and confidently advocate for themselves during pregnancy and birth.* Follow Andi:- https://yourlegaldoula.com/- Instagram @yourlegaldoulaAbout the Host:Danielle Plummer is a pharmacist, antepartum doula, and founder of Obstet-Rx. Through education, advocacy, and pharmacogenetics, she helps women navigate hyperemesis gravidarum and manage medications through complex pregnancy-related conditions.* Follow Danielle:- www.HGPharmacist.com- linkedin.com/in/daniellerplummerMemorable Quotes“We are not playing. We are here to have the birth experience that we want.”“Policy never overrides your rights.”“The most important work you are doing during your perinatal season should not be paperwork.”“The way we are treated during birth matters.”Resources Mentionedhttps://yourlegaldoula.com/https://hgpharmacist.com/Pregnant Workers Fairness Act (EEOC): www.eeoc.gov/Disclaimer:This podcast episode is intended for educational and informati

A leadership-level discussion on why drug shortages and supply instability continue to challenge pharmacy, and what executives must understand about operations, compliance, sourcing, and strategy to build a more durable supply chain.

In this episode of the PBM Reform Podcast, host Greg Reybold, Vice President and General Counsel at APCI, welcomes Josh Golden, Senior Vice President of Strategy at Judi Health and a nationally recognized voice in Pharmacy Benefit Manager reform. With more than 20 years of healthcare consulting experience, Golden brings deep expertise in vendor procurement, contract negotiation, plan design, and benefit strategy for large employers, government entities, and unions. Together, Reybold and Golden examine the financial models behind today’s PBM industry and why true transparency remains so difficult for employers, plan sponsors, patients, and pharmacies. The conversation explores how current PBM arrangements often benefit the PBMs more than the employers paying for coverage or the patients relying on their prescription benefits. Golden explains why auditing PBM contracts, rebate structures, spread pricing, administrative fees, pharmacy networks, and formulary decisions is essential to understanding the real economics of prescription drug benefits. This episode also addresses a growing concern in healthcare: PBM steering behavior. Are patients being quietly pushed toward specific formularies, specific pharmacies, and restricted networks that operate like closed networks without being clearly disclosed? Reybold and Golden discuss how this behavior can limit patient choice, disadvantage independent pharmacies, and distort the stated goal of lowering drug costs. The discussion also tackles the role of federal reform efforts, including whether the Appropriations Act represents meaningful PBM accountability or whether it risks becoming another layer in the broader shell game surrounding PBM reform. Finally, the episode asks one of the most important questions in pharmacy policy today: should PBMs own pharmacies? If vertical integration is promoted as a way to lower drug costs, where is the proof — and who actually benefits? Transparency, Auditing, and the PBM Shell Game | PBM Reform

This is a corporate-focused, conversational interview between Pharmacy Podcast Network Host, Todd Eury and Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s unique approach to the U.S. generics market, its commitment to innovation and accessibility, and the company’s philosophy of “Doing Things Differently” by redefining what it means to be a generics partner. Stephen Beckman also shares insights into YARAL’s growth and key milestones since launching its first product in 2023, including the expansion of its product portfolio, investment in business development, and focus on building a strong company culture. Learn more at YARALPharma.com

On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most.   We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities.   As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense.   TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession.   Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes.   To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children’s Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm.   For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings.   Sponsored by Perigon Pharmacy 360 Listen & Subscribe Stay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part five of our six part series! We'd like to thank PantherX Rare for sponsoring this episode! On this episode we interview: Katie DiLorenzo, PharmD SVP - PantherRxAustin Russian - PantherRxAutumn Santeler -  Polar Tech IndustriesBen Heiser - Lumicera Health ServicesCaroline Girardeau, PharmD, MBA ACHCChris Stewart - PetauriNatalie Bedford - McKesson

What's the difference between marketing and advertising and why does it matter for your pharmacy? In this episode of the Bottom Line Pharmacy Podcast, Austin Murray sits down with Bruce Kneeland, longtime independent pharmacy advocate and host of the Pharmacy Crossroads podcast, for a candid conversation about what it really takes to grow an independent pharmacy in today's competitive landscape.Bruce shares his fascinating journey from a chance job posting at BYU that landed him in Fargo, North Dakota, to senior roles at Health Mart, AmerisourceBergen, and eventually becoming a consultant and road-tripper who has visited pharmacies coast to coast.In this episode, Bruce and Austin cover:- Marketing vs. advertising and why confusing the two is costing pharmacies patients- The word-of-mouth myth and why relying on it alone is "killing you slowly"- Messaging that connects how to talk about complex services like compounding in language patients actually understand- The B2B opportunity and why your real customer for compounding and specialty services might be the prescriber, not the patientAnd more!

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part four of our six part series! We'd like to thank JB Consulting for sponsoring this episode!   On this episode we interview: Shaun Jensen - JB Consulting GroupLindsay Greenleaf - ADVIMagnar Kvilhaug - Odin Pharmacy Innovations LLCMarina Allen - RxAccess PartnersMatt Hare - CoverMyMedsRichard Brook - Better Health WorldwideValerie Mondelli and Colin Banas - DrFirst

On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy’s provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part three of our six part series! We'd like to thank Pergion Pharmacy 360 for sponsoring this episode! Chris Antypas PharmD - Perigon Pharmacy 360Chris Corsi - CassianRxChristen Roy - InovalonRobert Ojeda - K&B Pharmacy Associates

Today’s guest and I fundamentally agree on the basic premise of the body’s innate wisdom and capacity to heal, especially when we view it in a broader ecological context. According to him, infertility doesn't mean the body is broken; it's actually making intelligent, adaptive, and protective decisions made by the 4 foundational systems of the body that created life in the first place based on environmental conditions, resources, safety, and energy. Nick Dorsey, FDN-P, is a systems-based fertility and health educator, biochemist, and former chemistry educator who helps couples understand why fertility shuts down even when labs look normal and they're doing all the right things. With a Master's in biochemistry and over a decade teaching chemistry, physics, and environmental science, he translates complex biology into a clear understanding of how the body makes decisions. Nick’s research and experience supports that the body isn't broken, it's adapting intelligently to depletion, toxicity, and chronic stress, and symptoms like inflammation, fatigue, anxiety, gut dysfunction, and unexplained infertility are protective signals from a system in survival mode.Nick teaches health through the Four Pillars of biological readiness: the microbiome as the environmental interface, mitochondria as energy and resource allocators, minerals as the electrical and enzymatic stabilizers of physiology, and the nervous system as the regulator of safety and coherence. Rather than chasing symptoms, his work restores these systems so the body can repair, regulate, and reproduce when conditions are biologically appropriate. Functional labs reveal patterns of adaptation that explain why the body is saying not now, and what it needs next.Nick works with individuals and couples through high-touch, data-informed programs, with a long-term commitment to healthy pregnancies, births, and families across generations. He's a father of two with another on the way, both born at home, and long before biochemistry he spent most of his life teaching, coaching, and supporting children, including leading a youth ministry for kids with disabilities. Connect with Nick  via:Email: Nick@functionalchemistry.com IG: @FunctionalChemistryYT: @FunctionalChemistry10

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part two of our six part series! We'd like to thank Nested Knowledge for sponsoring this episode!   On this episode we interview: Keith Kallmes - Nested Knowledge Hannah Baxter and Andrew Rouff, MMIT - The Dedham Group Heather Bonome - URAC Jeremy Richardson - Gifthealth Joe DePinto - McKesson Johny Kello - MatchRx Shawn Griffin - URAC

This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice. In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment. In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient’s most relevant risk, helping reduce alert fatigue and improve workflow. Finally, we review a federal court ruling in Eli Lilly’s lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue.Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma’s marketing materials and public communications around its generic version of Amarin’s fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies. Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care.

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.  This is part one of our six part series! We'd like to thank Clearway Health for sponsoring this episode!   On this episode we interview:   Allison Arant - Clearway Health Jennifer Noonan - Accessia Health  Aleata Postell - CenterWell Derek Dennis, PharmD - Clearway Health  Dr. Shafaat Pirani, PharmD, BCGP - Wellgistics Health Meghna Misra - Claritas Rx

In this episode of Executive Dose, Marc Essensa, CEO at IPC, joins the conversation to discuss what leadership looks like inside community pharmacy during one of the most pressured moments in the profession. The episode explores how vision, strategy, ethics, and creative thinking can help independent pharmacies not only survive, but compete and grow.  Marc and Stephen examine the realities facing pharmacy owners today, including reimbursement pressure, shrinking margins, labor challenges, operational overload, and the emotional toll of pharmacy closures. The discussion moves beyond day-to-day survival and focuses on what separates leaders who react from those who lead with clarity and discipline. The episode also highlights the importance of building a business model that can compete, using partnerships, technology, operational efficiency, and new service models to create long-term value. Marc also speaks to the role of business ethics and trust, emphasizing that in community pharmacy, leadership character is not optional — it is part of the business strategy. Key Topics Leadership under pressure in community pharmacy How pharmacy owners can lead with vision during uncertainty Strategic mistakes that weaken independent pharmacies Operational efficiency, differentiation, and growth opportunities The role of IPC in helping pharmacies compete Why ethics, transparency, and trust matter in pharmacy leadership Creativity, courage, and innovation in the future of community pharmacy

A strong marketing strategy depends on the variety and relevance of your content. In this episode, we dive into what a diverse content strategy is, why it matters, and how it can elevate your marketing efforts. We’ll highlight the key benefits of producing varied content, common pitfalls to avoid, and practical tips for integrating different content types across your channels. Tune in to learn how to engage your audience more effectively, strengthen your online presence, and make your marketing work harder for you.

Today’s guest on the podcast shares how to proactively preserve both one’s health span and “beauty span”: the visible vitality, confidence, and connection to self over time. We got into some juicy and controversial topics around aging and the beauty industry, as well sustainability.My guest asserts that aging is not a passive process, it is something we can actively manage. Her mission is to help people understand that beauty, energy, and longevity are interconnected. When you support the body at a cellular and hormonal level, you don’t just look better, you function better.Dr. Sofia Din is a board-certified Family Physician with over 25 years of medical experience and advanced training in Geriatrics. She began her career in hospital medicine and long-term care, where she served as a Medical Director, before shifting her focus from disease management to proactive longevity and anti-aging medicine.She is the Medical Director of Juvanni Medical P.C. in Westchester, New York, where she integrates aesthetics, hormonal health, and advanced non-surgical technologies to help patients navigate menopause, andropause, metabolic slowdown, and chronic skin failure.Dr. Din is also the author of Do We Really Need Botox? and the host of the podcast Bathroom Diaries, where she explores the science, psychology, and cultural dimensions of aging, beauty, and self-perception.Connect with Sofia via:— Juvanni Med Spa:Email: juvannimedspa@gmail.com Website: Botox Guru at Juvanni Med SpaFB: Juvanni Med SpaIG: @drjuvanniYT: @DrJuvanniTwitter/X: @JuvanniMedSpaLinked In: Juvanni Medical— Dr. Sofia Din:FB: Sofia DinIG: @therealdrjuvanniYT: @DrJuvanniTikTok: @botoxguruLinked In: Sofia DinPodcast (Spotify): Bathroom Diaries w. Dr. Sofia Din— Minerva Life:YT: @minervalife6529TikTok: @sofiadinmdVisit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Sponsored by Rx4RouteThis Week in Pharmacy returns with a timely two-part episode focused on pharmacy operations, medication access, and the growing responsibility of healthcare communicators in the age of AI.In our first segment, we welcome Joseph Dymowski, PharmD, CEO of Centennial Pharmacy Services, and Doniyor Sattarov, Vice President of Operations at Rx4Route, for a conversation about expanding long-term care pharmacy at home. As more patients age in place, pharmacies must rethink delivery, logistics, documentation, and patient communication as essential parts of care.Delivery is no longer just a convenience. It is a critical extension of pharmacy services. Reliable routing, real-time tracking, and proof of delivery help pharmacies improve adherence, reduce operational friction, and build stronger trust with patients, caregivers, and providers.Expanding LTC pharmacy-at-home services, building scalable delivery workflows, improving route efficiency, using delivery technology to support compliance, and why logistics may become a major competitive advantage for pharmacies.This episode is sponsored by Rx4Route, pharmacy delivery software designed to help pharmacies streamline delivery operations, optimize routes, track orders, and improve proof-of-delivery workflows.In our second segment, we speak with **Vincent Grippi, CEO of Grippi Media, about the dangers of AI-generated misinformation and the higher standard required in healthcare communications. As AI becomes more common in content creation, communications professionals must protect accuracy, credibility, and patient trust.In healthcare, misinformation can influence clinical understanding, damage reputations, and create confusion across the industry. That is why content for healthcare professionals must be reviewed, verified, and guided by human judgment.AI misinformation in healthcare, responsible content development, source verification, editorial review, subject-matter expertise, and how communicators can use AI without sacrificing trust.This episode connects two critical forms of trust in pharmacy: operational trust at the patient’s door and informational trust across every communication channel.Featured Guests:Joseph Dymowski, PharmD— CEO, Centennial Pharmacy ServicesDoniyor Sattarov— Vice President of Operations, Rx4RouteVincent Grippi— CEO, Grippi Media

This episode we look at a bunch of statements from the FDA and from HHS Secretary Robert F. Kennedy, Jr. And of course there are peptides to talk about these days. Does anyone really know what’s going on with those?Our deep dive is a special one: Our guest is Al Carter, the CEO of the National Association of Boards of Pharmacy, and he gives us a totally different perspective on the regulatory landscape at the level that affects pharmacists every day.Links from the podcast:The latest FDA statement on DTE: https://fllw.me/4sL6zXw The Coalition for Compounding Excellence’s first audit process guide (compounding records and quality control): https://fllw.me/3Oew1qr FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C National Association of Boards of Pharmacy: https://nabp.pharmacy Join APC! https://a4pc.org/join

On this episode of the Cardinal Health™ Counter Talk™ Podcast, host Jason Callori explores the benefits of co-branding your pharmacy with the Medicine Shoppe International, Inc. (MSI) franchise. The episode features Tony Ibrahim, a multi-store owner with the Medicine Shoppe® Pharmacy network, and Lance Mindt, a MSI Franchise Business Consultant.   Tony and Lance discuss how pharmacies can benefit from co-branding their stores while maintaining their local brand identity through the co-branding model. Learn how independent pharmacies can preserve their local identity, streamline operations and foster growth while gaining the support and expertise of a national franchise.   Click here to learn more about co-branding.

Welcome back to PPN – The Precision Medicine Pharmacist. In part one of our series, Precision Psychiatry in Practice – A Pharmacist–Physician Collaboration, we explored how a collaborative approach can begin to reshape psychiatric care — building trust, aligning perspectives, and creating space for more personalized treatment. Today, we move deeper into what that looks like in real-world, integrative medicine psychiatry. I’m excited to welcome back Dr. Saba Arshad, joined by Dr. Afshan Khan, as we explore how their partnership brings together different clinical perspectives to care for the whole patient — not just symptoms, but the broader context of mental health, lifestyle, and individualized needs. In this episode, Precision in Practice: Real Stories, Real Results in Integrative Psychiatry, we focus on the human side of collaboration. How do two clinicians with different training and strengths come together to approach complex cases? What does shared decision-making really look like in practice? And how does this integrative model shape better patient outcomes? We’ll walk through real patient cases, explore the dynamics of their collaboration, and uncover how this partnership continues to evolve to meet patients where they are. If part one introduced the foundation, today’s episode brings that collaboration to life. Let’s dive in.

Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026! This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up.https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact.   Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summitMayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care. Where Gross-to-net Pressure Actually Lives After LaunchToday’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.htmlThe article explains that “gross-to-net pressure” isn’t driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated.Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for CongressDr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico’s 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare after graduating from the University of New Mexico College of Pharmacy and went on to found and lead a successful compounding pharmacy serving her community.  Motivated by nearly two decades of patient care experience, Okpareke entered the political arena to address challenges such as healthcare access, rising costs, and the shortage of providers in New Mexico. Running as a Republican, she emphasizes strengthening healthcare systems, supporting economic growth, and preserving opportunity for future generations, positioning herself as a community-focused leader bringing frontline healthcare insight into public policy.  This special episode highlights how TJM Labs is redefining pharmacy operations through AI-driven automation, bringing together insights from industry leaders Bhavesh Patel, PharmD—CEO of Carepoint Pharmacy—and Jonathan Adly, PharmD, MBA—CEO of TJM Labs. At the center of the conversation is how modern pharmacies are facing rising prescription volumes, staffing constraints, and increasing operational complexity, and why traditional manual workflows can no longer keep pace. TJM Labs addresses this challenge by deploying AI-powered “digital workers” that automate tasks like prescription intake, data entry, and patient communication—allowing pharmacy teams to shift their focus back to patient care and clinical decision-making.  Through the lens of both operator and innovator, the discussion explores how AI is not replacin

AI in healthcare is no longer a futuristic concept. It’s already answering the phones at your local CVS. We’re pulling back the curtain on how AI is currently being used in pharmacy practice, from encrypted "VA GPT" systems for note-writing to controversial new phone bots that some patients claim are a "stain on society".We dive into the big news of the CVS and Google Cloud partnership to launch Health100, a platform designed to integrate your refills, copays, and even wearable health data into a single AI-driven hub. While the promise of centralized care sounds like a dream, the "real-world" experience can feel like a nightmare. We react to a brutal Reddit thread and even call a CVS live to demonstrate the frustration of wrestling with a robot that refuses to transfer you to a human. Whether you're a "tinfoil hat" wearer worried about data leaks or someone just trying to get a prescription after surgery, you need to hear the clinical and personal reality of the AI takeover.This show is intended for educational and informational purposes.

Tennessee lawmakers have passed a major pharmacy reform bill aimed at pharmacy benefit managers, or PBMs, by barring companies from owning both a PBM and a pharmacy. The legislation is widely seen as targeting CVS Health, which owns Caremark and operates pharmacies across the state.Supporters say the bill is designed to curb vertical integration, restore fair competition, and protect independent pharmacies from reimbursement practices they view as harmful to patient access and community pharmacy survival.CVS has pushed back hard, warning that the new law could force it to shut down its 134 Tennessee pharmacy locations and trigger a legal challenge. The company argues the measure would reduce access for patients and does not directly address broader PBM issues like pricing or formularies.This Tennessee fight reflects a larger national battle over PBM reform, pharmacy ownership, market power, and the future of prescription drug access.

Clinical Pearls, Pain Pod edition: Pain Pearls Part 2 (of many) with Dr. Sing Ping Chow, PharmD as we discuss methadone, buprenorphine, gabapentin, pain pharmacists, AI, and beyond!A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod!Come one, come all, to the Pain Pod!!!P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us or LinkedIn to directly reach Mark and have your voice heard!

What does it actually mean to be healthy if your labs come back "normal" but you still feel terrible?For too many high-achieving professionals, that question goes unanswered for years. Today's guest knows that experience firsthand and has built her entire practice around closing that gap.Ekat is a Nutritional Therapy Practitioner (NTP), Restorative Wellness Practitioner (RWP), and Board-Certified Integrative Nutrition Health Coach. After 16+ years on Wall Street, she experienced firsthand what chronic stress, long hours, and burnout can do to a body, and what conventional medicine often misses when it does. Through her virtual practice, Healthfully Ekat, she helps busy, high-achieving women uncover the root causes behind persistent digestive issues, hormonal imbalances, and chronic fatigue using functional lab testing, personalized nutrition, and holistic lifestyle strategies.Her message is as straightforward as it is powerful: you're only going to be as successful as your health allows you to be.In this episode, we talk about what it really takes to stop guessing and start understanding what your body actually needs, so your energy, gut, and hormones can work for you instead of against you.In this episode, we cover:• Why "normal" labs don't always mean optimal health• The connection between chronic stress, gut health, and hormonal chaos• How functional lab testing changes the root cause conversation• The microbes we often ignore but shouldn’t (including parasites!)• What high-performing professionals consistently get wrong about their health• Why true success requires your body to keep up with your ambitionConnect with Healthfully Ekat via:Email: healthfullyekat@gmail.com Website: https://www.healthfullyekat.com/ IG: @healthfully.ekatVisit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Guests:Gil BasheChair Global Health and Purpose at FINN PartnersMaya HajizadaChief Revenue Officer at Rx2GoC. Daniel MullinsProfessor at University of Maryland School of PharmacyMina G Yacoub PharmD BCPSFounder & CEO at Qik Productions

This is the Pharmacy Profit Summit Live Recap Show! Welcome to Part Two.Pharmacy owners from across the US have come together to learn ways to improve their pharmacy's profit and bring better value to their patient's. The Pharmacy Podcast Network brings you this exclusive "man on the street" coverage of the show with interviews hosted by Todd Eury talking to the attendees, speakers, and vendors.In this episode, we hear interviews with: Pete Nagel - CurifyLabs Christopher Flores - Payment Processing Doug Soupon - RxOneShop Fiona Sartoretto Verna Omar - Utopia Pharmacy

“My doctor says it’s safe, but Google says it’s not… what do I do?” It’s the reality so many pregnant and breastfeeding moms face when they’re given conflicting medication advice. In this episode, consulting pharmacist Dr. Danielle Plummer and clinical pharmacist Dr. Tara Birch pull back the curtain on pregnancy medication confusion and why it happens. As Tara puts it, “Pharmacists need to be utilized more than they are. We are medication specialists.” The core message is clear: every mom needs a pharmacist as part of her care team. From preconception through the postpartum period, pharmacists bring the medication expertise that is often missing and can prevent confusion, errors, and unnecessary risk. From the overwhelm of choosing a prenatal vitamin to navigating mixed messages from providers and “Dr. Google,” they walk through what’s actually happening behind the scenes and how to make safer, more confident decisions.You’ll hear why “there is no one-size-fits-all prenatal vitamin,” how postpartum needs can increase during breastfeeding, and why a truly collaborative care team leads to better outcomes for both mom and baby. If you’ve ever second-guessed a medication, felt confused by conflicting advice, or wished you had a clear, trusted voice guiding you, this conversation will change how you approach your care.What You’ll Learn:- Why pharmacists are underused in maternal care- How to handle conflicting medication advice- How to choose the right prenatal vitamin- Why postpartum nutrition matters- The risks of relying on Google or AI for medication decisions- How collaborative care improves outcomesExpert Insights:- Pharmacists in Maternal Care: Pharmacists are medication experts but are often excluded from care teams. Including them improves safety and outcomes.- Conflicting Advice: Patients often receive mixed guidance from providers. Pharmacists help clarify evidence-based decisions.- Prenatal Vitamins: Not one-size-fits-all. Needs vary by diet, genetics, and symptoms.- Postpartum Nutrition: Nutrient needs may increase after delivery, especially during breastfeeding.- Gaps in Care: Hospital care is collaborative. Outpatient care is fragmented, creating safety risks.- Preconception Planning: Medication review before pregnancy can prevent first-trimester risks.Connect with Dr. Tara Birch:https://themotherbabypharmacist.comwww.instagram.com/themotherbabypharmacist/Phone/Text: 321-609-5424Connect with Dr. Danielle Plummer:www.HGPharmacist.comlinkedin.com/in/daniellerplummer

In this episode, we explore YARAL Pharma’s latest move to expand patient access to prescription topical patches through a new collaboration with UpScriptHealth. The partnership brings YARAL’s prescription topical treatments to a direct-to-consumer telehealth platform, giving patients a way to consult with licensed clinicians online and, when appropriate, receive prescriptions through participating pharmacies. The announcement reflects a broader shift in how pharmaceutical manufacturers are using digital health channels to improve convenience, affordability, and access to care.  We also examine what this means for the evolving pharmacy and telehealth landscape. YARAL Pharma said the collaboration supports its focus on continuity of supply, quality, customer service, and broader access to generic medicines, while UpScriptHealth highlighted its long-standing role in direct-to-patient telehealth services and its history of helping patients access care and prescriptions through online channels.  What You’ll Learn in This Episode:YARAL Pharma’s prescription topical patches are now available through UpScriptHealth’s telehealth platform. Patients can use the platform to connect with licensed healthcare providers virtually, determine eligibility, and potentially receive a prescription fulfilled through participating pharmacies. YARAL described the collaboration as part of its effort to expand access to affordable generic medicines through digital channels.  The episode also highlights the companies behind the announcement. YARAL Pharma is the U.S. generics subsidiary of IBSA, and UpScriptHealth describes itself as a direct-to-patient telehealth company that has helped facilitate more than two million prescriptions and works with a network of hundreds of physicians.  Key Discussion Points:  YARAL Pharma’s prescription topical patches are now offered through UpScriptHealth’s telehealth platform.   The partnership creates a direct-to-consumer path for online consultation and prescribing, when clinically appropriate.   YARAL says the move strengthens patient convenience and supports access to affordable generic treatment options.   UpScriptHealth brings an established national telehealth network and direct-to-patient infrastructure to the collaboration.   The announcement signals continued momentum in telehealth-enabled prescription access and digital pharmaceutical distribution. This last point is an inference based on the stated goals and structure of the partnership.

Welcome to the Pharmacy Podcast Network's special 3-Part series on the coverage of the American Pharmacist Association's Annual Conference event held in Los Angeles, California on March 27-31st. In this series, you'll hear from 4 key social media influencers having a massive impact on Pharmacy Advocacy, innovators exploring the advancing technology and use of AI in Pharmacy, and more! In this episode, we hear from: Stephen Beckman - Yaral Pharma Kati Forbes, PharmD Robbie Abasi, PharmD, Xavier Hill, PharmD, and Sam Llona, PharmD - RxRated Podcast Katlyn - Student at University of Montanna Sakhi Gaurang Patel - CuraVoice   Thank you to Yaral Pharma and the Independent Pharmacy Cooperative (IPC) for sponsoring this episode!